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Résumé (en français) 
Les cellules T invariantes associées aux muqueuse (MAIT) sont des lymphocytes 
innés caractérisés par l'expression d'un récepteur des cellules T semi-invariant (iTCR) 
et restreints par la molécule du complexe majeur d'histocompatibilité de classe Ib, 
MR1. Chez l'homme, les cellules MAIT sont abondantes dans le sang (1 à 10%), 
l'intestin (3 à 5%) et le foie (20 à 40%) et réagissent contre des métabolites 
microbiens. En raison de leur rareté dans les souris de laboratoire classiques, les 
études sur les cellules MAIT murines ont été principalement effectuées sur des souris 
transgéniques (Tg) pour des TCR MAIT. Cependant, ces cellules MAIT Tg ne 
récapitulent pas de manière adéquate le phénotype des cellules MAIT humaines. Ici, 
nous décrivons une souche de souris congénique que nous avons générée qui possède 
des cellules MAIT qui ressemblent aux cellules MAIT humaines. Nous utilisons cet 
outil pour étudier les caractéristiques des cellules MAIT murines. 
L'étude de souches de souris consanguines d'origine sauvage montre que la souche 
CAST/Ei présente une fréquence des cellules MAIT nettement supérieur à celle 
retrouvée dans la souche C57BL/6. Un seul locus est impliqué et a été localisé dans la 
région TCRα. Ceci a permis la génération d'une souche "MAIT" congénique, qui ont 
été en outre croisé à une souris Tg pour un rapporteur GFP du facteur transcriptionnel 
RORγt sur la base de données antérieurs montrant que les MAITs humaines 
expriment ce facteur. Grâce à cet outil, nous montrons que les MAITs murines sont 
CD4
−
CD8
−/lo
, ont un phénotype mémoire effecteurs (CD44
+
) et coexpriment PLZF et 
RORγt. Ces MAITs murines sont orientées vers une localisation tissulaire 
(CCR6
+
CCR7
−
) et résident préférentiellement dans les tissus non lymphoïdes 
périphériques, y compris les poumons, le foie et la peau. Après stimulation du TCR, 
les MAITs produisent des cytokines TH1/2/17 et sont aussi activées par de antigènes 
bactériens (par exemple semi-purifié fraction bactérienne ou 5-OP-RU) d'une manière 
dépendant de MR1. Les MAITs ont une forte expression de récepteurs de cytokines 
(IL-7R, IL-18Rα, IL-12Rβ) et peuvent ainsi répondre à des cytokines innées. Lors 
d'une infection expérimentale des voies urinaires, les MAITs migrent vers la vessie et 
ont une activité protectrice anti-bactérienne. 
Au total, nos résultats démontrent que les cellules MAIT murines ressemblent 
étroitement à leurs homologues humains. Ce nouveau modèle murin sera un outil 
puissant pour faire avancer notre compréhension de la biologie des cellules MAIT en 
situation normale et pathologique. 
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Abstract 
Mucosal-associated invariant T cells (MAIT) are innate lymphocytes that express a 
semi-invariant T cell receptor (iTCR) and are restricted by the major 
histocompatibility complex (MHC) related molecule, MR1. In human, MAIT cells are 
abundant in the blood (1-10%), gut (3-5%), and liver (20-40%). They react against 
microbial-derived riboflavin metabolites that are common in bacteria and yeast. Due 
to the paucity of MAIT cells in classical inbred laboratory mice, studies on mouse 
MAIT cells were mostly performed in TCR-transgenic (Tg) mice. However, these Tg 
MAIT cells do not adequately recapitulate the phenotype of human MAIT cells. 
Herein, we present a recently generated congenic mouse strain harboring MAIT cells 
that closely resemble human MAIT cells and use this tool to study the characteristics 
of natural mouse MAIT cell.  
An analysis of wild-derived inbred mouse strains revealed that CAST/Ei strain has 
increased frequency of MAIT cells than C57BL/6 mice. This was linked to a locus on 
the TCRα region. Introduction of such locus into C57BL/6 mice generated a “MAIT” 
congenic strain, which were further crossed to Rorc(γt)-Gfp
TG
 reporter strain based on 
previous findings of RORγt expression on human MAIT cells. Using this tool, we 
show that natural mouse MAIT cells are CD4
−
CD8
−/lo
, display an effector memory 
phenotype (CD44
+
), and coexpress the transcription factors PLZF and RORγt. They 
exhibit tissue-homing properties (CCR6
+
CCR7
−
) and preferentially reside in 
peripheral non-lymphoid tissues, including lung, liver, and skin. Upon TCR ligation, 
MAIT cells produce TH1/2/17 type cytokines and react to bacterial-derived antigens 
(i.e. semi-purified bacterial fraction or 5-OP-RU) in an MR1-dependent manner. They 
have high expression of cytokine receptors (IL-7R, IL-18Rα, IL-12Rβ) and may 
respond to the corresponding innate cytokines. During experimental urinary tract 
infection, MAIT cells migrate to the bladder and display a protective anti-bacterial 
activity.  
Altogether, our results demonstrate that mouse MAIT cells resemble their human 
counterparts more closely than previously recognized and therefore this new mouse 
model will be a powerful tool for advancing our understanding of MAIT cell biology 
in health and disease. 
 
Keywords: MAIT cell, wild-derived inbred mice, RORγt  
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Abbreviations 
APC   Antigen presenting cell 
B6   C57BL/6 
CAST   CAST/Ei 
CMV   Cytomegalovirus 
DAG   Diacylglycerol 
DHA   Dihydroxyacetone 
DN   Double negative (CD4
−
 CD8
−
) 
Glyx   Glyoxal 
GSL   Glycosphingolipid 
HCV   Hepatitis C virus 
HIV   Human immunodeficiency virus 
IBD   Inflammatory bowel disease 
iGb3   Isoglobotrihexosylceramide   
ILC   Innate lymphoid cell 
iNKT   Invariant natural killer T cell 
iTCR   Invariant TCR 
LFA-1   Lymphocyte function-associated antigen-1 
mAb   Monoclonal antibody
 
MAIT   Mucosal associated invariant T cell 
MeG   Methylglyoxal 
MHC   Major histocompatibility complex 
MLN   Mesenteric lymph node 
PIM4   Phosphatidylinositol tetramannoside 
PLZF    Promyelocytic leukaemia zinc finger  
PMA   Phorbol 12-myristate 13-acetate  
RA   Rheumatoid arthritis 
rRL-6-CH2OH Reduced 6-hydroxymethyl-8-D-ribityllumazine 
RL-6-Me-7-OH 7-hydroxy-6-methyl-8-D-ribityllumazine 
RL-6,7-diMe  6,7-dimethyl-8-D-ribityllumazine 
ROR   Retinoic acid receptor-related orphan receptor 
SLE   Systemic lupus erythematosus 
SNP   Single nucleotide polymorphism 
SPF   Specific pathogen-free 
TB   Tuberculosis 
TCR   T cell receptor 
TFH   T follicular helper cell 
Tg   Transgenic 
TH   T helper cell 
TLR   Toll-like receptor 
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5-A-RU  5-Amino-6-D-ribitylaminouracil 
5-OE-RU  5-(2-oxoethylideneamino)-6-D-ribitylaminouracil 
5-OP-RU  5-(2-oxopropylideneamino)-6-D-ribitylaminouracil 
6-FP   6-formylpterin 
α-GalCer   α-galactosylceramide 
β-GalCer  β-galactosylceramide 
β-GlcCer  β-glucosylceramide 
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Introduction 
Immune responses can generally be classified into two groups: innate and adaptive 
immunity. As its name suggests, innate immunity consists of cells and proteins that 
are always present and rapidly respond in sites where infections or cellular stress 
originate. The main components of innate immunity are physical epithelial barrier 
(e.g., skin, mucosa), phagocytes (e.g., macrophages, dendritic cells), and plasma 
proteins (e.g., complement). However, the diversity of antigens recognized by innate 
immune components is limited and nonspecific. Adaptive immune components, on 
the other hand, recognize almost infinite diversity of antigens. Although a naïve 
lymphocyte carries receptors with a single specificity, the specificity of each 
lymphocyte is unique resulting in diverse repertoires of these populations. This is 
dependent on the rearrangement of their antigen receptors. When naïve lymphocytes 
encounter their antigens, they undergo clonal expansion, differentiation and then 
migrate to the affected tissues, where they exert antigen-specific effector functions 
and provide long-term memory. However, not all immune cells behave according to 
the schema. Over the last two decades, the discovery of innate lymphoid cells (ILC) 
and innate-like T and B cells, such as γδ T cells and B1 cells, has blurred the 
boundary between innate and adaptive immunity
1
.  
A crucial feature of adaptive immune response is the release of a complex diversity 
of cytokines by T cells. Upon antigen recognition, T helper cells (TH) differentiate 
into different subsets, namely, TH1, TH2, TH17, TREG, TH9, and T follicular helper 
(TFH) cells
2
. These functional subsets thereby regulate immune responses through 
their distinct cytokine secretion patterns. Interestingly, the recently appreciated ILCs 
can produce many TH cell-type cytokines and mirror the expression of TH lineage-
specific transcription factors, despite a lack of antigen-specific T cell receptors
3
.  
Unlike classical lymphocytes, which recognize a large range of antigens, innate-
like lymphocytes express restricted antigen receptors that are semi-invariant or 
germline encoded and often self-reactive. Functionally, they appear to produce 
effector components more rapidly than convectional naïve lymphocytes
1
. Their 
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restricted repertoire and rapid effector functions follow the scheme of innate rather 
than adaptive immunity.  
Innate-like T cells require T cell receptor (TCR) for development but then alter 
their TCR responsiveness to accommodate their innate mode of activation
4
. Among 
TCRαβ T cells, two populations with semi-invariant TCR, known as invariant natural 
killer T (iNKT) cells and mucosal associated invariant T (MAIT) cells, were 
discovered in the early 1990s
5–8
. These two innate-like populations have distinct 
properties compared with mainstream T cells. As their names imply, these T cell 
populations have restricted TCRα usage paired with limited repertoire of TCRβ 
chains, suggesting a limited antigen recognition pattern. Unlike conventional T cells, 
which recognize peptide bound to polymorphic major histocompatibility complex 
(MHC) class I or II molecules, they recognize their cognate antigens presented by 
non-polymorphic, nonclassical and evolutionarily conserved MHC class I like 
molecules: glycolipid antigen bound to CD1d for NKT cells and vitamin B2 precursor 
metabolite bound to MR1 for MAIT cells
9–15
. Functionally, in response to antigen or 
cytokine stimulation, they produce copious amount of cytokines more rapidly than 
conventional naïve T cells
16–19
. In addition, they are mostly localized in mucosal 
tissues, where pathogens are first encountered.  
Despite their abundance in human and evolutionary conservation among species, 
the importance of MAIT cells have just recently been appreciated due to the finding 
of their anti-microbial function
20,21
. Over the past few years, MAIT cells have been 
implicated in a number of infectious and autoimmune diseases, however, their exact 
roles remain elusive, in part due to their scarcity in mice, which hampers in vivo 
studies and therefore the understanding of MAIT cell biology. This thesis will focus 
on the description of a recently established mouse model in which MAIT cells are 
naturally increased. This model herein allowed extensive phenotypic and functional 
analyses of mouse MAIT cells. An experimental urinary tract infection model was 
used to validate in vivo anti-bacterial function of these cells.  
Invariant TCRαβ T cells 
Invariant αβ T cells were originally described in 1993 as TCR αβ T cell subsets 
expressing invariant TCRα rearrangement in DN T cell compartment, including 
Vα24-Jα18 and Vα7.2-Jα33 (formerly Vα24-JαQ and Vα7.2-Jα(IGRJα14)), now 
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known as iNKT and MAIT cells
5
. Porcelli et al. suggested that these cells recognize a 
limited spectrum of antigens in the context of non-polymorphic antigen-presenting 
molecules, which were later found to be CD1d and MR1 respectively. iNKT and 
MAIT cells share many distinct and important properties compared with conventional 
T cells (Table 1). Interestingly, it seems likely that the frequencies of these two 
populations are inversely associated in both human and mice – for example, MAIT 
cells represent up to 40% of human liver T cells whereas iNKT cells account for 
merely 1% of such population
18,22
 – suggesting that iNKT and MAIT cells may have 
redundant functions. Given that iNKT cells have been studied more extensively than 
MAIT cells, we will firstly elaborate on some important properties of iNKT cells. 
 
 
Table 1. Characteristics of iNKT and MAIT cells compared to conventional T cells23–25 
Characteristic iNKT MAIT Conventional T  
TCRα chain 
hVα24-Jα18 
mVα14-Jα18 
hVα7.2-Jα33/12/20 
mVα19-Jα33 
Diverse 
Associated Vβ 
hVβ11 
mVβ8.2/7/2 
hVβ2/13.2 
mVβ6/8 
Diverse 
Restricting 
molecule 
CD1d 
Non-polymorphic 
MR1 
Non-polymorphic 
MHC-I or II 
Highly polymorphic 
Ligand Glycolipids, phospholipids 
Vitamin B2 precursor 
metabolites 
Peptides 
Selecting cells DP thymocytes DP thymocytes Thymic epithelium 
PLZF 
expression 
Yes Yes No 
Coreceptor CD4, DN, CD8αα CD8αα,  CD8αβ
int
, DN CD4 or CD8 
Frequency 
(% of CD3) 
0.0001-1% in blood, 1% in 
liver (human)  
1-3% in spleen, ≤50% in 
liver (mouse) 
1-10% in blood, 20-
40% in liver, 3-5% in 
gut (human) 
~0.1% in LP (mouse) 
~60% (CD4
+
), ~30% 
(CD8
+
) in blood 
(human) and spleen 
(mouse) 
Tissue 
distribution 
Liver, thymus, spleen, lung, 
BM, LN, and fatty tissue 
Liver, gut, lung, and 
blood 
Blood, lymphoid 
tissues 
Peripheral 
phenotype 
Memory Memory 
Naïve prior to 
antigen exposure 
Functional 
phenotype 
TH1/2/17 TH1/17 Diverse 
h, human; m, mouse; DP, double positive (CD4
+
CD8
+
); DN, double negative (CD4
−
CD8
−
); 
int, intermediate; LP, lamina propria; BM, bone marrow; LN, lymph node; MHC, major 
histocompatibility complex.
 
  
 11 
iNKT cells 
Functional Subsets of iNKT Cells 
iNKT cells have been classified into three functional subsets, NKT1, NKT2 and 
NKT17
26,27
 (Figure 1),  evident in their resemblance of TH1, TH2, TH17 cells, in terms 
of cytokine secretion pattern (i.e., IFN-γ,  IL-4 and IL-17) and the expression of 
lineage-specific transcription factor (i.e., T-bet, GATA-3 and RORγt). Consistent 
with their T-bet expression, NKT1 cells are capable of producing TH1 type cytokine 
IFN-γ, but also secrete low level of TH2 type cytokine IL-4. NKT2 cells, on the other 
hand, are GATA3
hi
 cells and mainly produce IL-4 and IL-13. Like TH17 cells, NKT3 
cells produce IL-17 and express higher levels of RORγt
27
. In addition to these 
lineage-specific transcription factors and cytokines, NKT1, NKT2, and NKT17 cells 
can also be distinguished as PLZF
lo
, PLZF
hi
 and PLZF
int
 cells according to the 
expression level of transcription factor promyelocytic leukaemia zinc finger (PLZF)
26
. 
PLZF is a master regulator of NKT linage and is induced immediately after positive 
selection. In the absence of PLZF, NKT cells fail to acquire effector-memory 
phenotype and exhibit a defective secretion of IL-4 and IFN-γ
28
. 
 
 
Figure 1. Functional subsets of iNKT cells. Characteristics of iNKT subsets, NKT1, NKT2, 
and NKT17, identified by intracellular expression of transcription factors, expression of 
surface markers, prominent tissue localization, and cytokine production. 
  
PLZFlo 
T-bet 
PLZFhi 
GATA-3hi 
PLZFint 
RORγt 
NKT1 NKT2 NKT17 
NK1.1+ CD4+/− 
CD122, CD212 
CXCR3 
Liver, spleen 
IFNγ, IL-4 
NK1.1− CD4+ 
IL17-RB 
CCR4 
Lung 
IL-4, 13 
NK1.1− CD4−  
IL-23R 
CCR6 
Peripheral LN, Skin 
IL-17 
 
Surface markers 
 
Localization 
Cytokine 
Transcription  
factor 
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In line with the identification of iNKT functional subsets, distinctive features of 
these cells have also been revealed
23,26,27
 (Figure 1). NKT1 cells express NK lineage 
receptors, including NK1.1, Ly49, NKG2D, CD94, and DX5, whereas NKT2 and 
NKT17 lack expression of these markers
26
. Other surface makers expressed by NKT1 
cells are also absent in NKT2 and NKT17 cells, for example, CD122 (IL-2Rβ), 
CD212 (IL-12Rβ2), and CXCR3. In contrast, NKT2 cells highly express IL-17RB, 
the receptor for IL-25, while NKT17 cell express IL-23R and CCR6
23,27,29
. The tissue 
localization of these subsets also varies, with NKT1 cells predominant in liver and 
spleen, NKT2 cells in lung and NKT17 cells in peripheral LN and skin
26,30
.  
iNKT Cell Activation 
iNKT cells recognize both exogenous and endogenous antigens presented by CD1d 
molecules
23
. Three distinct pathways mediated by microbial antigens, endogenous 
glycolipid antigens, or innate cytokines have been described for iNKT activation 
(Figure 2), 
17,23,31,32
.  
 
1. Microbial antigen mediated 
 
2. Endogenous antigen mediated 
 
 
TCR 
NKT 
CD1d 
IL-12R 
IL-12 
Foreign Ag 
TLR and Ligand IFN-γ 
TCR 
NKT 
CD1d 
IL-12R 
IL-12 
Self Ag 
TLR and Ligand IFN-γ 
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3. Innate cytokine mediated 
 
Figure 2. Activation pathways of iNKT cells. iNKT cells activation pathway (1) through 
foreign antigen recognition in which cytokines from APCs are less dependent, (2) by 
endogenous lipid antigens presented by APC, usually required for cytokines from innate cells, 
(3) or mediated solely by cytokines, irrespective of the expression of lipid antigens or TCR. 
Figures were generated using images from Servier Medical Art (www.servier.com), licensed 
under the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/ 
license/by/3.0/). 
 
Alpha-galactosylceramide (α-GalCer) was the first described antigen for iNKT 
cells which originated initially from marine sponge
33
. Subsequently, a series of 
naturally occurring microbial antigens were discovered, such as glycosphingolipids 
(GSL) from Sphingomonas spp.
34–36
, glycosylated diacylglycerols (Glc-DAG) found 
in Borrelia burgdorferi
37
 and Streptococcus pneumoniae
38
, phosphatidylinositol 
tetramannoside (PIM4) derived from Mycobacterium bovis BCG
39
, and cholesterol-
glycoside from Helicobacter pylori
40
. These microbial antigens can activate iNKT 
cells in a TCR-dependent manner during infection.  
In addition to direct recognition of exogenous antigens, iNKT cell can be activated 
indirectly by innate cytokines (e.g., IL-12) produced by antigen presenting cell (APC) 
upon toll-like receptor (TLR) activation, together with a weak TCR signal generated 
from ligation of endogenous lipid antigens
17
. Such pathway allows iNKT cells to 
respond to those pathogens that lack CD1d-restricted lipid antigens but express TLR 
ligands, such as virus and Salmonella typhimurium
36,41
. Currently known self-lipid 
antigens include β-galactosylceramide (β-GalCer), β-glucosylceramide (β-GlcCer), 
isoglobotrihexosyl-ceramide (iGb3), disialoganglioside, and self-phospholipid 
antigens as well as recently identified α-linked glycosylceramides
42,43
.  
Moreover, growing evidences suggest that iNKT cells can be activated by innate 
cytokines, regardless of TCR engagement
32,44–46
. Recently, using Nur77
gfp
 reporter 
mice, which have been used to identify cells with experience of antigen receptor but 
TCR 
NKT 
CD1d 
IL-12R 
IL-12 
TLR and Ligand IFN-γ 
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not inflammatory signaling, Holzapfel and colleagues demonstrated that iNKT cells 
produced IFN-γ but did not upregulate GFP in response to cytomegalovirus (CMV), 
Salmonella typhimurium or TLR stimulation, therefore they underwent TCR-
independent activation
32
. This finding agrees with another study in which iNKT cells 
stimulated with TLR agonists induced IFN-γ production, irrespective of the presence 
of TCR on mature iNKT cells
47
.  
MAIT cells 
MAIT cells were originally identified by their invariant TCR (iTCR) usage Vα7.2-
Jα33
5
 (Vα19-Jα33 in mice) and firstly described in 1990s
7
. However, strong interest 
on MAIT cells has been recently aroused due to the finding of their anti-microbial 
function
20,21
. The following sections will explore what is currently known about 
MAIT cells. 
MAIT Cell Phenotype 
As its name suggests, MAIT cells are mainly located in mucosal tissues, such as gut, 
liver and lung
18
 (Table 1). In human, they comprise 1-10% of blood T cells, 20-40% 
of liver T cells and 3-5% of intestinal T cells. Additionally, MAIT specific iTCR 
transcripts Vα7.2-Jα33/12 were also observed in kidney, tonsil, LN, prostate, and 
ovary
48
.  
Memory Phenotype and Tissue Tropism 
Human MAIT cells are identified as Vα7.2 CD161
hi
 T cells and are predominantly 
CD8
+
 or double negative (DN)
18,49
. A very minor subset of CD4
+
 MAIT cells has also 
been recognized by MR1 tetramers
50
. Human MAIT cells from adult peripheral blood 
have an effector memory phenotype (CD45RO
+
, CD62L
−
, CD95
+
) and exhibit tissue-
homing properties (CCR2
+
, CCR5
+
, CCR6
+
, CXCR6
+
, CCR9
+
, CCR7
−
)
18,51
. Whereas 
in cord blood, they express a naïve phenotype (CD45RA
+
, CD62L
+
) and bear the 
chemokine receptor CCR6
49,51–53
. A recent study suggests that MAIT cells from 
second trimester fetal tissues display various phenotypes
54
. In fetal thymus, spleen 
and mesenteric lymph node (MLN), MAIT cells express a naïve phenotype 
(CD45RO
lo
) while those from fetal liver, lung, and intestine seem to be memory-type 
cells (CD45RO
hi
, CD62L
lo
, CD25
hi
). Notably, the majority of CD161
hi
 cells in fetal 
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tissues are Vα7.2
−
 whereas those from adult are mostly Vα7.2
+ 
(<95%)
18,54,55
. In cord 
blood, CD161
hi
CD8
+ 
cells are already programmed to a MAIT-like phenotype and 
they are mostly Vα7.2
−
(~80%)
53
.
 
After birth, Vα7.2
+ 
MAIT
 
cells expand and dominate 
the CD161
hi
 population
52,55
. Whether similar developmental events occur in the fetal 
tissues remains to be addressed. However, unlike cord blood in which CD161
hi 
population comprises a minority of CD8 T cells, fetal tissues harbor a vast majority of 
CD161
hi
 population, raising the possibility that a classical MHC-restricted T cell may 
express CD161 along with Vα7.2. Without further confirmation of MR1 restriction by 
Vα7.2
+
CD161
hi 
population from fetal tissues (e.g. MR1-tetramer staining, TCR 
repertoire analysis, MR1 blocking assay), the phenotype of fetal MAIT cells is not 
conclusive.   
Surface Molecules CD161, CD26 and Cytokine Receptors 
In addition to their invariant TCR and mucosal localization, MAIT cells can also be 
identified by additional surface molecules and transcription factors.  
Together with Vα7.2, high expression of CD161 identifies all MAIT cells from 
periphery blood and jejunum
50
. Although the usage of CD161 antibody to define 
MAIT cells from tissues has been questioned, it is currently one of the most reliable 
and commercially available reagent to study MAIT cells in human. CD161, also 
known as NKR-P1A or KLRB1, is a C-type lectin receptor expressed by the majority 
(>90%) of NK cells and a large proportion (~24%) of peripheral T cells, including 
both αβ and γδ T cells
56
. CD161 expression has been associated with a memory 
phenotype and IL-17 secretion potential of circulating T cells
57
. On NK cells, ligation 
of CD161 results in an inhibition of cytotoxicity
56
. Regarding MAIT cells, opposing 
effects of CD161 ligation were reported
55,58
. Le Bourhis et al. showed that triggering 
of CD161 on MAIT cells inhibited their cytokine secretion but had no effect on 
cytotoxicity, whereas Fergusson and colleagues found an increased production of 
IFN-γ and TNF-α upon CD161 simulation.  
CD161 remains unchanged during overnight activation but its downregulation has 
been observed along with proliferation in response to E.coli
59
. Ligation of CD161 by 
its ligand or anti-CD161 also induces its transient downregulation
55
. Therefore, it may 
be unreliable to identify activated MAIT cells by merely using CD161. Additional 
markers and MR1-tetramers are definitely required to solve this problem. Recently, 
CD26, a dipeptidase that can cleave and inactivate a number of chemokines, has been 
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suggested to accurately identify human bacteria-reactive MAIT cells
60
. On 
unstimulated MAIT cells, CD26 are coexpressed with CD161. In response to bacteria, 
both molecules are downregulated
60
. However, downregulation of CD26 is less 
pronounced compared with CD161, thus providing an alternative to identify MAIT 
cells with a higher sensitivity.  
In addition, IL-18Rα also unequivocally identifies MAIT cells
20
. MAIT cells 
express the highest levels of IL-18Rα among all human T lymphocytes
51
. Expression 
of IL-18Rα by MAIT cells was also reported in cord blood, fetal liver, and mucosal 
tissues while only a small proportion of MAIT from fetal thymus, spleen, and MLN 
express this receptor, suggesting that MAIT cells may undergo a stepwise 
maturation
18,53,54
. Other cytokine receptors, such as IL-12Rβ, IL-23R and IL-7Rα, are 
also expressed by MAIT cells
18,51,55,61,62
. In contrast with IL-18Rα, IL-7Rα is 
universally expressed by fetal MAIT cells from either lymphoid organs or mucosal 
tissues
54
. Accordingly, the expression of cytokine receptors by MAIT cells in steady 
state suggests the potential reactivity of MAIT cells to cytokine stimulation. 
 
 
Figure 3. Phenotype of MAIT cell from peripheral blood. In addition to its iTCR, human 
MAIT cells express a variety of surface receptors, including CD8α and β coreceptor, NK 
receptors, tissue-homing chemokine receptors, cytokine receptors, as well as memory 
markers. They also express transcription factors PLZF and RORγt. 
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Transcription Factors PLZF and RORγt  
Expression of transcription factors PLZF and RORγt have been described in human 
MAIT cells. PLZF, also known as ZBTB16, is expressed by NKT cells, MAIT cells 
and a subset of γδ T cells (Vγ1-Vδ7.3)
26
. PLZF has been known to orchestrate 
acquisition of an innate-like effector program of NKT cells, including their effector-
memory phenotype and the ability to secrete IL-4 and IFN-γ at a single cell level
28,63
. 
Although NKT and MAIT cells share similar developmental program (i.e., thymic 
selection by DP thymocytes in the context of non-classical MHC-I molecules), their 
developmental pathways are distinct
64
. NKT cells expand and acquire an effector-
memory phenotype in the thymus, whereas MAIT cells remain naïve in both adult and 
fetal thymus
49,52,54
. In line with their naïve phenotype, low levels of PLZF were 
observed in fetal thymus
54
, suggesting PLZF may play a role in the development of 
MAIT cells. A recent study on mouse MAIT cells underlines the importance of PLZF 
for MAIT development
65
. Rahimpour et al. showed that MAIT cells were almost 
absent in thymus, spleen, and lymph nodes from PLZF knockout mice. In addition to 
its role on NKT and MAIT development, PLZF was also reported as an essential 
inducer of homing and adhesion properties of NKT cells
66
. Whether PLZF regulates 
MAIT cells in the same manner remains to be elucidated.   
RORγt is the other important transcription factor expressed by MAIT cells. RORγt 
was initially described as a key transcription factor of TH17 cells
67
, known to direct 
the differentiation program of these cells and to induce genes encoding IL-17
67
. Over 
the last few years, RORγt expressions by ILC, NKT cells, and γδ T cells were also 
reported
68–70
. Among CD8
+
 T cells, MAIT cells account for the majority of RORγt 
expressing cells
18,51,55
. Study on mouse MAIT cells using MR1 tetramer revealed two 
functional subsets of MAIT cells governed by the expression of transcription factor T-
bet or RORγt, consistent with their IFN-γ or IL-17 producing capacity
65
. Upregulation 
of T-bet was also observed in human MAIT cells stimulated with PFA-fixed E. coli
59
.  
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MAIT Cell Activation 
One of the most important findings in the field of MAIT research is the anti-microbial 
activity of MAIT cells against a broad range of bacteria and yeast
20,21
, which includes 
E. coli, Pseudomonas aeroginosa, Klebsiella pneumonia, Lactobacillus acidophilus, 
Staphylococcus aureus, Staphylococcus epidermidis, Mycobacterium abscessus, 
Mycobacterium tuberculosis, Salmonella typhimurium, Saccharomyces cerevisiae, 
Candida glabrata, and Candida albicans
20,21
. In contrast, Enterococcus faecalis, 
Streptococcus group A, and Listeria monocytogenes are not able to activate MAIT 
cells in an MR1-dependent manner
20,21
. MAIT reactivity to a wide range of microbes 
suggests the presence of common antigen(s) in these microbes
14,20,21
.  
MAIT Ligands and its TCR 
MAIT TCR is restricted to non-polymorphic MHC-I like molecule, MR1, that is 
highly conserved in mammals and displays high levels of cross-reactivity
71,72
. MR1 
transcripts and protein are ubiquitously expressed in all cell types and tissues, 
however their surface expression levels are exceedingly low
72
.  
Similar to other MHC-I and MHC-I like molecules, refolding of MR1 requires 
antigens to stabilize its structure. Interesting observation of MR1 refolded in cell 
culture medium RPMI 1640 led to the discovery of MAIT ligand – vitamin B 
metabolites
14
. However, the initial finding of folic acid (vitamin B9) metabolite 6-
formylpterin (6-FP), which stabilized MR1, was not able to activate MAIT cells
14
. 
The following work on refolding MR1 with the culture supernatant of Samonella 
typhimurium (previously described bacteria strain which activates MAIT cells
21,73
) 
revealed the stimulatory ligands with a mass to charge ratio (m/z) of 329.11, that are 
riboflavin (vitamin B2) derivatives: reduced 6-hydroxymethyl-8-D-ribityllumazine 
(rRL-6-CH2OH) (C12H18N4O7), 7-hydroxy-6-methyl-8-D-ribityllumazine (RL-6-Me-
7-OH) (C12H16N4O7) and its precursor, 6,7-dimethyl-8-D-ribityllumazine (RL-6,7-
diMe) (C13H16N4O6)
14
. Notably, the distribution of riboflavin biosynthesis pathway is 
consistent with the selective activation ability of previously described bacterial 
strains
20,21
.  
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Figure 4. Riboflavin biosynthesis pathway and formation of MAIT antigens. Riboflavin 
biosynthesis has been described in both Gram-positive and Gram-negative bacteria. 
Microbial synthesis from GTP and ribulose-5-phosphate occurs through seven enzymatic 
steps (Rib). The intermediate compound 5-A-RU is the precursor of MAIT cell antigen. It gives 
rise to lumazine derivatives (green) or pyrimidine adducts (red, MAIT antigens). Dismutation 
of lumazine derivatives yields riboflavin and 5-A-RU. The latter is then recycled in the 
pathway. Note: The riboflavin synthetic enzymes vary according to bacteria species. The 
enzymes from Lactococcus lactis
15
 (RibA, B, C, G, H) and E.coli 
74
 (RibA, B, C, D, E) are 
shown. 
 
 
To further identify the origin of MAIT ligand, culture supernatant from 
Lactococcus lactis with individual mutation in the four genes of riboflavin operon 
(RibGBAH) were tested for activation of Jukat. MAIT cells
15
. The study showed that 
MAIT activation required genes encoding enzymes that synthesize riboflavin (RibA 
and RibG) and revealed an important intermediate compound 5-Amino-6-D-
ribitylaminouracil (5-A-RU) which is the precursor of chemically unstable MAIT 
antigens 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-
oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU)
15
. These transitory antigens 
are formed via non-enzymatic reaction of 5-A-RU with glyoxal (Glyx) or 
methylglyoxal (MeG) –byproducts of other metabolic pathways – and are stabilized 
by MR1. Mass spectra detected a single m/z 329.11 species in MR1 refolded with 5-
A-RU and MeG (to form 5-OP-RU) suggesting the initially identified antigen was 5-
OP-RU
14,15
. Consistently, the m/z 315.09 species (corresponding to 5-OE-RU) were 
also identified in MR1 eluate from E.coli and S. typhimurium
15
. The importance of 
riboflavin metabolites for MAIT activation was also reported in mice
74
. Soudais et al. 
showed that in addition to Glyx and MeG, dihydroxyacetone (DHA), a metabolic 
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intermediate from glycolysis pathway, can also form MAIT antigens through non-
enzymatic reaction with 5-A-RU. Since DHA is unlikely to condensate with 5-A-RU 
under physiological conditions, this effect may result from the conversion of DHA to 
MeG. In the same work, stimulatory capacity of 5-OP-RU on murine MAIT cells was 
confirmed by MAIT activation following intraperitoneal injection of this compound 
into Vα19-Tg mice.  
MAIT cells are characterized by their canonical invariant TCRα Vα7.2-Jα33 
(TRAV1-2–TRAJ33), which pairs with an array of TCRβ chains dominated by 
Vβ2/13 (TRBV20/6)
5,7,48,50,73
. Functionally, invariant TCRα chains mediate 
interaction with MR1, in which two residues centrally located on opposing sides of 
antigen-binding cleft of MR1 are essential for MAIT activation, whereas TCRβ usage 
fine-tunes MR1-TCR recognition, therefore MAIT responses in an antigen-dependent 
manner
73,75
.  
Recently, by using MR1 tetramer, additional Jα usages Jα20/12 (TRAJ20/12) were 
identified in human MAIT cells
50
. Vα7.2-Jα12 subset was also revealed in another 
study using deep sequencing
48
. Lepore et al. showed Vα7.2-Jα12 T cells represent a 
significant fraction of circulating MAIT cells. These cells react to riboflavin-
synthesizing bacteria, exert cytotoxicity against intracellular bacteria, and are able to 
secrete TH1/2 cytokines. In some donors or tissues, such as colon, they outnumber 
canonical Vα7.2-Jα33 MAIT cells
48
. In addition, Gold et al. evaluated MAIT TCR 
repertoire against different microbes (Mycobacterium smegmatis, Salmonella 
typhimurium, and Candida albicans) and found heterogeneity of TCR usage, 
especially for TCRβ chains
76
. This study raises the possibility that MAIT cells may 
expand in response to specific pathogen. Indeed, this observation requires further 
confirmation as MAIT cells were defined as CD8 T cells that express TRAV1-2 
(Vα7.2) and secrete TNF in response to bacterial stimulation, without using MAIT 
specific markers such as CD161 or IL-18Rα. Hence, a proportion of conventional T 
cell expressing the same TCR may be included in the analyses. In agreement with the 
above study, Eckle et al. demonstrated that CDR3β hypervariability regulated MAIT 
TCR recognition via changing TCR flexibility and contacts with MR1 and antigens
75
. 
Collectively, these studies suggest that MAIT cells may be able to discriminate 
microbial antigens and selectively expand by fine-tuning their TCR.  
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Cytokine Secretion 
In response to phorbol 12-myristate 13-acetate (PMA) and ionomycin, peripheral 
blood MAIT cells are able to secrete TNF-α, IFN-γ, IL-17, and IL-2 but not IL-10, or 
TH2 cytokines, whereas stimulation with E. coli-infected monocytes induces mainly 
IFN-γ production
18,61
. Similar cytokine mRNA profile was also observed in hepatic 
MAIT cells
61
. Moreover, intracellular staining showed that MAIT cells represented 
most of IL-17 producing cells in the liver and IL-17
+
MAIT also co-produced IFN-γ 
but not IL-22
61
. In addition, Lepore et al. suggested that circulating MAIT cells 
comprise sub-populations with distinct cytokine expression profiles. In the three 
tested donors, most of the subsets secreted IFN-γ, MIP-1β, TNF-α, and IL-2 while IL-
4 and IL-10 producer were less frequent
48
. In this study, MAIT cells were identified 
as Vα7.2
+
CD161
+
 cells, herein CD8
+
 MAIT cells cannot be distinguished from the 
CD4 subset. Whether a unique cytokine profile is linked to a specific co-receptor 
usage remains to be determined. Study on Vα7.2-Jα12/33 clones showed that upon 
stimulation with E. coli-infected THP-1 cells, these MAIT clones released TH2 
cytokines (IL-4, 5, 10 and 13) together with TH0 (GM-CSF), TH1 (IFN-γ, TNF-α) 
cytokines but not IL-17
48
. TH2 cytokine responses to TCR ligation was also observed 
in MAIT cells from Vα19 transgenic mice
77
. Furthermore, following stimulation with 
PFA-fixed E.coli and anti-CD28 mAb, fetal intestinal MAIT cells released IL-22 and 
IFN-γ, while fetal liver and lung solely elicited IFN-γ
54
. In contrast, MAIT cells from 
fetal thymus, spleen and MLN produced IFN-γ in response to PMA/ionomycin but 
not E. coli stimulation
54
. The production of IL-22 was also reported in blood MAIT 
cells from patients with inflammatory bowel disease
78
. Collectively, MAIT cells have 
a TH1/17 cytokine secretion profile and, to a much less extent, are capable to produce 
TH2 cytokine. Their cytokine secretion pattern may reflect the maturation state, 
antigen exposure history, their tissue distribution, as well as microenviromental cues. 
How different cytokine releases is regulated and their physiological relevance in 
health and disease remain to be addressed.  
Cytotoxicity 
One of the most important features of MAIT cells is their anti-microbial activity. In 
murine models, their contribution in controlling bacterial infections has been 
demonstrated in many reports, included E.coli, Mycobacterium abscessus, Klebsiella 
pneumonia, Mycobacterium bovis bacillus Calmette-Guérin (BCG) as well as 
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Francisella tularensis infections, in which cytokine release from MAIT cells were 
proved essential
20,79–81
. In addition to cytokine secretion, human MAIT cells were also 
reported to be cytotoxic as they produced granzyme B in response to bacteria 
stimulation
18
. A recent study demonstrated that MAIT cells could detect and kill 
epithelial cells infected with invasive Shigella flexneri, suggesting their function in 
control of bacteria dissemination
58
. A second report supports the above study
59
. 
Kurioka et al. showed that upon stimulation, MAIT cells exchanged their cytotoxic 
granule contents (granzyme A and K in resting cells; granzyme B and perforin in 
stimulated cells) and are licensed to kill cognate target cells, including APC, with 
greater efficiency. Moreover, this report suggested that in addition to TCR, a second 
signal, such as cytokine, was required for potent cytotoxicity as the blocking of IL-12 
compromised the induction of granzyme B and perforin. This exquisite regulation 
may be important to prevent unnecessary host damage
59
.  
MAIT Activation  
Freshly isolated blood MAIT cells are in a nonproliferating state, as they barely 
express Ki67
18
. Similar feature was also described in adult liver MAIT cells
61
. 
However, MAIT cells from fetal tissues express considerable levels of Ki67 and 
readily proliferate in response to fixed E.coli and its supernatant
54
. Increased levels of 
proliferation were also observed in cord blood following TCR stimulation
62
. The high 
proliferation rate of MAIT cells found in fetal tissues and cord blood may reflect their 
developmental stages. Although adult MAIT cells poorly respond to TCR stimulation, 
their proliferative responses could be induced by costimulation with anti-CD28 or 
innate cytokines
59,62
. Moreover, MAIT cells also respond to E.coli and are ready to 
proliferate, being Ki67
+ 
for about 60% of the population
59
. Their proliferating 
capacity are inhibited by blocking with anti-MR1 antibody. 
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Figure 5. Activation of MAIT cells
82,83
. (1) APCs uptake microbes and present foreign 
antigen – vitamin B2 metabolites – to MAIT cells via MR1-iTCR interaction. (2) Microbial 
components also trigger pathogen recognition receptors (e.g., TLR8) resulting in the release 
of innate cytokines (e.g., IL-12, IL-18). (3) The responsiveness of MAIT cells can be 
enhanced by costimulation with coreceptor CD28 or innate cytokines. (4) Activated MAIT cells 
produce TH1/17 cytokines and exhibit cytotoxicity. (5) IL-7 enhances cytokine secretion of 
hepatic MAIT cells through the regulation of TCR-signaling components. Figures were 
generated using images from Servier Medical Art (www.servier.com), licensed under the 
Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/ 
license/by/3.0/). 
 
MR1-dependent MAIT activation to bacteria was initially studied, in which 
blockade of MR1 abrogates the upregulation of early activation marker CD69 and 
diminishes the production of IFN-γ by MAIT cells
20
. However, MAIT cells poorly 
respond to TCR stimulation, showing low cytokine production compared to mitogen 
stimulation
18,61,62,84
. This raised the question of whether MAIT activation could also 
be induced by a TCR-independent manner (as shown in iNKT cells, Figure 2). The 
low responsiveness of MAIT cells to TCR stimulation is due to the down- or up-
regulation of genes encoding positive and negative regulators in TCR signaling 
pathway that are yet distinct from those of exhausted and anergic T cells
62
. Similar to 
their induction of proliferative response, low cytokine production by MAIT cells can 
also be restored by costimulation with anti-CD28 or innate cytokines
59,62
. Given that 
resting MAIT cells express high levels of IL-7R, IL-12R, and IL-18R, the role of 
corresponding cytokines has been established in a number of studies. A recent study 
on human liver MAIT cells showed that IL-7 – a cytokine produced by hepatocytes 
during inflammation – enhanced cytokine production of MAIT cells through the 
regulation of TCR-signaling components
61
. Yet this observation requires further 
confirmation as bulk liver mononuclear cells were incubated with IL-7. Therefore, 
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whether this was a specific effect or a bystander consequence remains to be 
determined. Using recombinant cytokines IL-12, IL-18, and Toll-like receptor (TLR) 
agonists, Ussher et al. demonstrated that MAIT cells respond to innate cytokine 
stimulation in an TCR-independent manner
19
. The subsequent study on liver MAIT 
cells showed that MAIT cells indirectly responded to TLR8 agonist depending on 
secretion of IL-12 and IL-18 by ssRNA-activated intrahepatic monocytes
84
. These 
results broaden the potential responsiveness of MAIT cells to non-riboflavin-
synthesizing bacteria, virus, as well as inflammatory stimuli. Responses to innate 
cytokines were also reported in iVα19-Tg murine models where innate cytokine IL-12 
rather than MR1 dominated MAIT activation and their effector functions in control of 
BCG infection
80
. Similar results were showed in pulmonary Francisella tularensis 
infection
81
. Collectively, these studies suggest that multiple factors regulate MAIT 
responsiveness during infection and infer their potential role in inflammatory diseases.  
MAIT Cell in Human Diseases 
Bacterial Infection 
The role of MAIT cells in bacterial infection was initially studied in Mycobacterium 
tuberculosis infection. MAIT cells are present in human lung and react to 
Mycobacterium tuberculosis in vitro
21
. In individuals with active tuberculosis (TB), 
the frequency of MAIT cells decreases in the peripheral blood and pleural effusions 
compared with healthy subjects, suggesting that they may migrate to the inflamed 
lung and contribute to the local responses
20,21,85
. The subsequent functional study 
showed that in response to BCG but not E.coli stimulation, MAIT from TB 
individuals produced moderately higher amount of IFN-γ and TNF-α compared to 
healthy individuals
85
. This finding led the authors to propose that MAIT cells might 
selectively expand upon antigen exposure in TB patients, as suggested in reference
76
. 
Moreover, as MAIT from TB individuals expressed elevated levels of inhibitory 
receptor PD-1, blockade of PD-1 resulted in a higher production of cytokines 
following BCG activation, therefore PD-1 on MAIT cells could be a potential target 
for TB immunotherapy
85
.  
Decreased frequency of circulating MAIT cells was also observed in a clinical trial 
testing the efficacy of an oral Shigella vaccine
58
. A specific reduction of MAIT cells 
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was observed on day 11 post vaccination. When analyzing vaccine responder and 
non-responder separately (based on specific IgA responses), increased MAIT 
proportion and upregulation of activation marker HLA-DR were only observed in 
responder group. However, the relation between MAIT activation and specific IgA 
response remains to be addressed.   
Similarly, reduction of circulating MAIT cells in bacterial infection has also been 
addressed in many other reports, including Pseudomonas aeruginosa pulmonary 
infection, Vibrio cholerae infection in children, as well as septic patients with severe 
bacterial infections
86–88
.  
Viral Infection 
In addition to bacterial infections, decreased circulating CD161
hi
 Tc17 cells, mostly 
MAIT cells, were also reported in patients with chronic hepatitis C (HCV)
51
. Instead, 
these cells were found enriched in liver and their prevalence was inversely correlated 
with the clinical disease score, suggesting that they may contribute to the control of 
disease progression
51
. As previously discussed, hepatic MAIT cells indirectly respond 
to TLR8 agonist ssRNA and produce IFN-γ
84
. Similar responses were also present in 
pathologic livers, such as those with HBV and HCV infections
84
. This raises the 
question of whether MAIT can act as a therapeutic target for the treatment of liver 
diseases.  
Likewise, in early and chronic human immunodeficiency virus (HIV) infection, 
circulating MAIT population was found to be severely decreased and failed to recover 
following anti-retroviral therapy, whereas their number in rectal mucosa was 
relatively preserved
89–91
. In addition, the residual circulating MAIT cells were 
functionally impaired from individuals infected with HIV for 6-8 years
90
. It has been 
reported that HIV impaired mucosal epithelial barrier integrity resulting in microbial 
translocation and therefore systemic immune activation
92
. Accordingly, the loss of 
MAIT cells and their functional impairment may contribute to the increased 
susceptibility to microbial infection in HIV patients, thus rescue of MAIT cells may 
help restore host defense in immunodeficient patients.  
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Autoimmune Diseases 
As discussed above, MAIT responsiveness to innate cytokines and their localization 
at mucosal surface implicate that they may play a role in autoimmune diseases. The 
frequency and potential function of MAIT cells in different autoimmune diseases are 
summarized in table 2. Although MAIT cells have been associated with various 
autoimmune diseases, how they function and contribute in these diseases is an open 
question that warrants further investigation. A physiologically relevant mouse model 
will indeed benefit the understanding of MAIT cells under (patho-)physiological 
conditions.  
Table 2. MAIT cells in inflammatory diseases 
Disease Blood Inflamed Site Function 
MS
93
 ! " ND 
MS
94
 " ND 
Pathogenetic potential 
through IFN-γ production 
MS
95
 # ND 
Protective potential: 
Suppress IFN-γ produced 
by pathogenic TH1 cells  
Psoriasis
96
 ND 
Slightly increase in 
dermis, but decrease in 
epidermis (ns) 
Pathogenetic potential 
through IL-17 production 
Asthma
97
 # # 
Protective potential:  
Their deficiency correlates 
with clinical severity 
Type I diabetes
98
 
CD27
−
 
MAIT " 
ND 
Pathogenetic potential 
through IL-17 production 
Type II diabetes and 
obesity
99
 
# 
!, but higher than in 
blood
Pathogenetic potential 
through IL-17 production 
Inflammatory Bowel 
Disease (IBD)
78
 
# " 
Pathogenetic potential 
through IL-17 production 
Systemic lupus 
erythematosus 
(SLE) and 
rheumatoid arthritis 
(RA)
100
  
# 
In RA patient, higher in 
synovial fluid than 
blood 
Their deficiency correlates 
with clinical severity.  
Kidney and brain 
tumor
101
 
ND CD56
−
MAIT infiltration 
Anti-tumor potential through 
TH1/17 cytokine production 
#"!, deceased, increased or preserved MAIT levels in patients, compared with 
healthy donors; ND, not determined; ns, not significant 
  
  
 27 
Laboratory Mouse Strains 
Mice are commonly used model organism and experimental tool in immunological 
research and in many respects they mirror human biology. Notably, mouse genome 
sequencing revealed about 30,000 genes, with 99% having analogues in human
102
. 
Among many reasons to use mouse as an experimental model, the most important 
ones are: their genetic isogenicity, ease of genetic manipulation, possibility to perform 
in vivo analyses, and the limited accessibility to human samples
103
. The use of such 
model shed lights on human immunology. However, as mouse and human diverged 
millions of years ago, significant differences exist between the two species. The 
differences include lifespan, body size, and ecological niche, which have huge impact 
on immune system
104
. Hence, such differences should be taken into account when 
interpreting and translating murine findings to human. 
Figure 6. Origin of classical inbred laboratory mouse strains. Classical inbred mouse 
strains were bred in early 20
th
 century from a limited number of founding ‘fancy’ mice. The 
genetic contributions of Mus musculus subspecies to the haplotypes of laboratory strains are 
indicated.  
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Classical Inbred Strains 
Most laboratory mouse strains, including commonly used C57BL/6, BALB/c, 
C3H/He, and 129/Sv strains, were derived from Mus musculus (M.m.) domesticus, M. 
m. musculus, M. m. castaneus, and the hybrid M. m. molossinus. The genetic 
contributions of each subspecies are 68%, 6%, 3% and 10%, respectively
105
. The 
ancestral origin of the remaining 13% of haplotypes is unknown (Figure 6)
105
. Due to 
the limited number of founder mice, these inbred strains represent only a small 
proportion of the genetic diversity of their ancestors.   
TCR-Transgenic Strains and MAIT Cells 
Unlike in human, the frequency of MAIT cells in classical inbred mouse strains is 
exceedingly low
7
. The lack of iTCR Vα19 specific antibody or surrogate makers has 
made it more challenging to study these cells in mice. Therefore, studies on mouse 
MAIT cells were mostly performed in TCR-transgenic (Tg) mice (i.e., Vα19-Tg, 
Vβ6-Tg, and Vα19-Vβ6-Tg) in which the MAIT iTCRα chains or/and its preferential 
pairing TCRβ chains were overexpressed. These Tg strains have been used to 
investigate MAIT development
49,64
, microbial reactivity
20
, and their implication in 
bacteria infections
20,80
 and inflammatory diseases
106,107
. Notably, these Tg MAIT cells 
do not adequately recapitulate the phenotype of human MAIT cells as they lack the 
expression of transcription factor PLZF and exhibit a naïve phenotype whereas MAIT 
cells in human are memory and express PLZF
49
. Tg MAIT cells were derived from T-
T hybridoma using peripheral T cells form TAP
−/− 
Ii
−/−
 mice and were selected based 
on TCRα usage
7
. Therefore they may not be fully tolerant to MHC-I or II molecules. 
Moreover, in the absence of exogenous ligand, a number of hybridoma were found to 
react against MR1-overexpressing cells lines suggesting that they may exhibit 
autoreactivity to MR1-expressing cells or respond to the riboflavin metabolites 
antigen from the culture media uptaken by MR1
71
. In addition, the newly defined 
MR1-tetramer identified that more than 40% of tetramer
+
 cells from Vα19-Tg mice 
are CD4
+
, in contrast to human MAIT cells in which only a small population 
expresses CD4
50
. Unexpectedly, MR1-tetramer also detects tetramer
+ 
cells in Vα19-
Tg MR1
−/−
 mice in which the restriction molecule MR1 is absent
50
. In some studies, 
TAP and Ii knockout genes were introduced, leading to a low frequency of 
conventional T cells. Such models lack the physiologic integrity, therefore are 
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inappropriate to address the immunoregulatory or nonredundant role of MAIT cells. 
Thus, it remains to be determined whether these inconsistencies between Tg and 
human MAIT hold true for naturally occurring mouse MAIT cells. 
Wild-derived Inbred Strains 
In addition to above classical inbred strains, there are also wild-derived inbred strains, 
which represent more divergent genetic origins compared to the classical ones. Wild-
derived inbred mice were established from mice captured in the wild at different times 
and locations, which were then inbred to homozygosity
105
. They are derived directly 
from major taxonomic groups of Mus musculus subspecies, such as CAST/Ei 
(M.m.castaneus), MOLF/Ei (M.m.molossinus), PWD/Ph (M.m.musculus), and 
WSB/Ei (M.m.domesticus). Among wild-derived inbred strains, CAST/Ei represent 
the lowest genetic contribution to the haplotype of classical strains (3%), resulting in 
a higher density of DNA polymorphisms than other strains
108
. Thus, there is a higher 
possibility to identify natural variation in CAST/Ei. Indeed, CAST/Ei have been used 
to identify loci affecting on various phenotypes, such as growth and obesity
109
, B 
lymphocyte deficiency
110
, hearing loss
111
, and axonal regeneration in CNS
112
. 
Identification of these loci requires genetic mapping approach which links phenotype 
of interest to polymorphic makers of known chromosomal location, such as single 
nucleotide polymorphism (SNP)
113
. Moreover, among common inbred strains, 
densely distributed SNPs (average density of 1 SNP per 311 base pairs) facilitate the 
identification of causative genetic changes
105
. 
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Results 
Aim of the study 
The aim of the study in this thesis was to identify natural (non TCR Tg) mouse MAIT 
cells, to analyze their phenotypic and functional features and ultimately to generate a 
mouse model to study MAIT cells in health and disease.  
Findings and conclusions 
Due to the scarcity of MAIT cells in classical inbred mice, we set up a screen for 
MAIT iTCR Vα19-Jα33 expression in wild-derived inbred strains, among which, 
CAST/Ei (CAST) harbor 20 fold higher of MAIT iTCR than that of classical 
C57BL/6 (B6) mice.  
The crossing of CAST mice to the B6 background caused a dichotomous 
segregation of MAIT iTCR Vα19-Jα33 expression in the N2 progeny. Genetic 
mapping identified a single locus on the TCRα region accounting for the expression 
of Vα19-Jα33 and allowed the generation of a B6-MAIT
CAST
 congenic strain. 
Although the exact molecular mechanism was not elucidated, the TCRα repertoire 
analysis revealed that the usage of distal Vα segments was increased in CAST mice 
while Jα remained unchanged compared with those of B6 mice. Notably, Vα19 is the 
most distal Vα, thus the general increase of distal Vα usage contributed to the higher 
frequency of MAIT cells in CAST mice.  
Given that human MAIT cells express the transcription factor RORγt
18,51,55
, we 
introgressed Rorc(γt)-Gfp
TG
 reporter gene
114
 onto B6-MAIT
CAST
 congenic mice and 
used RORγt-GFP as a surrogate maker to label MAIT cells.  
Using this tool, we have characterized that natural mouse MAIT cells are 
CD4
−
CD8
−/lo
 and display an effector memory phenotype (CD44
+ 
CD62L
−
) and tissue-
homing properties (CCR6
+
CCR7
−
). Higher frequency of MAIT cells are present in 
non-lymphoid tissues such as liver, lung, skin, and gut than in lymphoid organs 
including spleen and MLN.  
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Similar to their human counterparts, mouse MAIT cells express high levels of 
cytokine receptors (IL-7R, IL-18Rα, IL-12Rβ) and coexpress transcription factors 
PLZF and RORγt. Moderate levels of NK1.1 and CXCR6 are also expressed by 
hepatic but not splenic MAIT cells.  
Upon TCR ligation, TH1/2/17 type cytokines are detected in the supernatant of 
purified MAIT cell culture. Intracellular cytokine staining showed that in response to 
anti-CD3/CD28 beads or PMA/ionomycin, MAIT cells exclusively secrete IL-17 
whereas stimulation with E.coli-infected bulk splenocytes mainly induce IFN-γ 
releases. 
In addition, mouse MAIT cells specifically respond to bacterial-derived antigens 
(i.e., semi-purified E.coli supernatant or 5-OP-RU) in an MR1-dependent manner. 
During experimental urinary tract infection, MAIT cells migrate to the bladder and 
display a protective anti-bacterial activity.  
Collectively, the “MAIT” congenic strain allows the phenotypic and functional 
study of naturally occurring mouse MAIT cells in health and disease.  
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Introduction
Mucosal-associated invariant T cells (MAITs) express an invari-
ant TCR-α (iTCR-α) chain (iVα7.2-Jα33 in human and iVα19-Jα33 
in mouse) restricted by the major histocompatibility complex 
(MHC) class I–related protein 1 (MR1) (1–4). MAITs recognize 
bacteria-infected cells (5, 6) and display antimicrobial activity 
in several experimental infection models (6–8). There is a strict 
correlation between the capacities of a bacterial strain to acti-
vate MAITs and to synthesize riboflavin (vitamin B2) (rib) (6, 9). 
Indeed, MAITs specifically recognize derivatives of the rib bio-
synthetic pathway, which is absent from mammals, but present 
in most bacteria and in yeasts (9, 10).
MAITs are decreased in the blood of patients suffering from 
subacute (5, 6) or acute infections (11) and are detected at the site 
of infection. The frequency of MAITs is also modified in nonbac-
terial diseases: increased in recently diagnosed multiple sclerosis 
patients (12, 13), but decreased in obesity, type-2 diabetes (14), 
inflammatory bowel disease (15), and HIV (16–19).
MAITs are CD4–CD8– (DN) (and also CD8αα in humans) or 
CD8αȕint. They are abundant in the blood (1%–10%), gut (3%–5%), 
and liver (20%–50%) of humans, but are extremely rare in labo-
ratory mouse strains (20–22). The disparity in frequency between 
species contrasts with the high conservation of both the TCR-α 
and MR1 molecules, which indicates a strong evolutionary selec-
tion pressure and thereby important functions (23).
The phenotype and functional properties of MAITs are 
much better known in humans than in mice. Human MAITs 
from adult peripheral blood display an effector memory pheno-
type (CD45RO+, CD62L−, CD95+) and tissue-homing features 
(CCR2+, CCR5+, CCR6+, CXCR6+, CCR9+, CCR7−) (21, 24). They 
secrete high amounts of IFN-Ȗ, TNF-α, and granulocyte-mac-
rophage CSF (GM-CSF) and have the potential to secrete IL-17 
and IL-22 (21, 24–26), but not Th2 cytokines (21, 27). MAITs are 
cytotoxic for epithelial cells infected by invasive bacteria (28, 29). 
In addition to TCR triggering, MAITs can be activated by innate 
cytokines such as IL-12 and IL-18 (25, 30). Consistent with their 
innate-like features and IL-17 secretion capacity, MAITs express 
the transcription factors ZBTB16 (promyelocytic leukemia zinc 
finger [PLZF]) and RAR-related orphan receptor Ȗ (RORȖt) (21, 
24, 31, 32).
In the cord blood, human MAITs display a naive phenotype, 
and their TCR-ȕ repertoire is diverse (21, 22). After birth, MAITs 
expand to reach high clonal size (20, 33). This contrasts with the 
low cell-division rate of MAITs in human adult blood, shown by low 
Ki-67 expression (21, 34). Taken together, these data indicate that 
MAITs either proliferated during childhood or undergo division in 
the tissues and recirculate to the blood once resting.
Mucosal-associated invariant T cells (MAITs) have potent antimicrobial activity and are abundant in humans (5%–10% in 
blood). Despite strong evolutionary conservation of the invariant TCR-α chain and restricting molecule MR1, this population 
is rare in laboratory mouse strains (≈0.1% in lymphoid organs), and lack of an appropriate mouse model has hampered the 
study of MAIT biology. Herein, we show that MAITs are 20 times more frequent in clean wild-derived inbred CAST/EiJ mice 
than in C57BL/6J mice. Increased MAIT frequency was linked to one CAST genetic trait that mapped to the TCR-α locus and 
led to higher usage of the distal Vα segments, including Vα19. We generated a MAIThi congenic strain that was then crossed 
to a transgenic Rorcgt-GFP reporter strain. Using this tool, we characterized polyclonal mouse MAITs as memory (CD44+) 
CD4–CD8lo/neg T cells with tissue-homing properties (CCR6+CCR7–). Similar to human MAITs, mouse MAITs expressed the 
cytokine receptors IL-7R, IL-18Rα, and IL-12Rȕ and the transcription factors promyelocytic leukemia zinc finger (PLZF) and 
RAR-related orphan receptor Ȗ (RORȖt). Mouse MAITs produced Th1/2/17 cytokines upon TCR stimulation and recognized a 
bacterial compound in an MR1-dependent manner. During experimental urinary tract infection, MAITs migrated to the bladder 
and decreased bacterial load. Our study demonstrates that the MAIThi congenic strain allows phenotypic and functional 
characterization of naturally occurring mouse MAITs in health and disease.
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specific pathogen–free (SPF) facilities (6). However, the number 
of MAITs was still much lower than that found in humans. This 
could be due to a lack of a specific bacterial strain or combination 
thereof that is only found in humans.
To test this hypothesis, we reconstituted breeding GF mice 
with a human microbiota and examined the frequency of MAITs 
in the pups 4 to 8 weeks after weaning. To increase the reliability 
of our experiment, we used Tap–/– Ii–/– mice, which harbor 10-fold 
more MAITs than C57BL/6J (B6) mice (32). We verified that the 
human microbiota had implanted (Supplemental Figure 1; supple-
mental material available online with this article; doi:10.1172/
JCI82424DS1) and measured MAIT frequency in the colon lam-
ina propria (LP) by quantitative reverse-transcription PCR (RT-
qPCR) of the specific Vα19-Jα33 (iVα19) TCR-α chain transcripts. 
We found that the frequency of MAITs in mice reconstituted with 
human microbiota was similar to that found in mice from our SPF 
facility (Figure 1A). This result suggests that the small number of 
MAITs found in mice from SPF animal facilities is probably not 
due to the absence of specific microbes or combinations thereof.
The CAST/EiJ mouse strain harbors 20 times more MAITs than 
B6 mice. To test the genetic hypothesis that would explain the low 
number of MAITs in laboratory mice, we next measured MAIT 
frequency in SPF inbred mouse strains harboring a wider genetic 
diversity than conventional laboratory mice. Among 7 wild mouse 
strains tested (data not shown), we found 2 with increased fre-
quency of MAITs: Mus musculus castaneus (CAST/EiJ abbreviated 
CAST) and Mus musculus musculus PWK (Figure 1B). We focused 
on the CAST strain that harbored the highest frequency of MAITs 
(15.4 ± 7.3 AU, mean ± SD). To assess the genetic basis of this phe-
notype, we crossed CAST (MAIThi) to B6 (MAITlo) to generate F1 
mice. The frequency of MAITs in F1s was intermediate (Figure 1B). 
To determine the number of loci involved, we crossed the F1s to 
B6s to generate N2s (Figure 1B). The N2s segregated into 2 groups 
of roughly equal size with either low or intermediate frequency of 
MAITs, suggesting that only 1 locus is responsible for the MAIThi 
phenotype. This result allowed a straightforward linkage analysis 
on 66 N2s using 4,700 informative SNPs distinguishing B6 and 
CAST. We identified a single locus in a 20-Mb region on chromo-
some 14 (Figure 1C) linked with the MAIThi phenotype. To confirm 
this analysis, we also generated F2s and correlated the iVα19 levels 
in mesenteric lymph nodes (MLNs) with the genotypes (B6/B6, 
B6/CAST, CAST/CAST) of the previously mapped regions (Figure 
In contrast to human, mouse MAITs are extremely rare in com-
mon laboratory mouse strains. So far, the study of MAIT physiol-
ogy has mostly relied on mice that are Tg for the MAIT TCR chains. 
Several iVα19 TCR-α Tg strains have been produced (32, 35, 36). 
In iVα19 Tg Ca–/– (to prevent the expression of endogenous TCR-α 
chains) mice, on an MR1-sufficient background, the DN and CD8lo T 
cells display an increased usage of the Vȕ6 and Vȕ8 TCR-ȕ segments 
(32, 36, 37). Most of these Vȕ6+ or Vȕ8+ T cells are activated by bacte-
ria (6, 38). These TCR-α Tg models allow the study of MAIT specific-
ity and antibacterial activity in vitro and in vivo (6, 39, 40), even if, in 
contrast to humans, most MAITs display a naive CD44lo phenotype 
(32). This is probably related to the forced premature expression of 
the TCR-α chain transgene, which also greatly modifies the function-
ality of the Tg T cells (41). This casts doubt on the relevance of these 
TCR Tg laboratory mouse models for studying the physiological 
functions of MAITs. Likewise, in non-TCR Tg mouse models, anti-
body-mediated (8) or genetic (6) depletion of conventional T cells 
was necessary to evidence the role of MAITs in experimental infec-
tions. Thus, the phenotype as well as the function of naturally occur-
ring mouse MAITs in health and disease remains to be addressed.
Two possibilities arise to explain the low frequency of MAITs 
in laboratory mice: (a) mice from animal facilities lack specific 
bacterial strains or communities in their microbiota that are neces-
sary to sufficiently expand MAITs or (b) during the genetic bottle-
neck that occurred upon their establishment, laboratory mice lost 
an allele necessary for MAIT peripheral activation, expansion, or 
survival. We first studied the environmental hypothesis and then 
found that laboratory mouse strains have lost one genetic element 
implicated in MAIT development. A “MAIThi” congenic strain was 
generated and further crossed to a Rorcgt-GFPTG reporter strain. 
Most of the GFP+ memory DNCD8lo T cells were identified as 
MAIT, according to the expression of the iVα19 TCR-α chain and 
MR1 dependence. Using this tool, we analyzed the phenotype, 
peripheral expansion, and functions of naturally occurring mouse 
MAITs in health and in experimental urinary tract infection (UTI).
Results
Reconstitution of germ-free mice with human microbiota is insuf-
ficient to increase the number of MAITs above that found in specific 
pathogen–free-raised mice. We previously showed that coloniza-
tion of germ-free (GF) mice with 1 microbial species is sufficient 
to increase the number of MAITs to the levels found in mice of 
Table 1. Fine mapping of the MAIThi locus in informative recombinant mice generated during backcrossing MAITCAST phenotype to B6
Mbp (on chromosome 14)
Vα19-Jα33A 53.70 54.25 54.40 54.70 54.83 54.86 55.00 56.00 57.00
0.7 B6 B6 B6 B6 B6 B6 B6 Het Het
0.44 B6 B6 B6 B6 B6 B6 Het Het Het
2.35 B6 B6 B6 B6 B6 Het Het Het Het
0.95 Het Het B6 B6 B6 B6 B6 B6 B6
6.99 Het Het Het Het Het B6 B6 B6 B6
10.74 Het Het Het Het Het Het Het B6 B6
AVα19-Jα33 mRNA levels measured by RT-qPCR in blood or MLNs. Fold change relative to B6 MLNs, after normalization to Cα. Bold indicates the most 
informative recombination point.
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TCAST mice was used to reconstitute irradiated CD45.1 congenic 
mice. In these chimeras, the presence of the MAITCAST trait in the 
hematopoietic compartment resulted in increased MAIT frequen-
cy in the different organs (Figure 2B), indicating that the MAITCAST 
phenotype is hematopoietic intrinsic.
To better investigate the mechanisms leading to the increased 
rate of Vα19-Jα33 usage, we quantified the usage of the differ-
ent Vα and Jα segments in the thymus of B6, BALB/c, and CAST 
strains. We used a 5′ RACE TCR-α amplification step followed by 
deep sequencing (42). Because the Vα segments rearrange to the 
Jα segments in a sequential and orderly fashion beginning with the 
most 3′ Vα and 5′ Jα segments and the Vα19 segment is the most 5′, 
the frequency of the iVα19-Jα33 rearrangements might be propor-
tional to the usage of the most distal (5′) Vα segments. We indeed 
observed a much higher usage of the distal Vα segments in CAST 
mice as compared with B6 mice (Figure 2C), while no difference 
was found with regards to Jα usage (Supplemental Figure 2A). The 
increased usage of distal Vα segment in CAST could result from 
the lack of a Vα triplication that is exclusively present in B6 mice 
(Figure 2C and ref. 43). Hence, we quantified the Vα segments in 
thymocytes from BALB/c mice, which also lack this triplication: 
the distal Vα usage was slightly increased, but did not reach CAST 
levels (Figure 2C), in agreement with MAIT iTCR-α frequency 
1D). The results fully confirmed the linkage analysis and indicate 
a strong gene-dosage effect.
Increased frequency of MAIT-specific iTCR-α rearrangement 
in CAST mice. As only 1 locus was involved in the MAITCAST phe-
notype, we generated a B6-MAITCAST congenic strain that would 
have a high number of MAITs on a B6 background by backcrossing 
the MAITCAST trait to B6 for more than 10 generations. The addi-
tional recombinants generated during this process allowed us to 
narrow down the MAIThi locus to the TCR-α region (Table 1). This 
0.6-Mb region does not include the iVα19 (TRAV1)segments, but 
encompasses the 3′ end of the Vα locus, TCR-δ, Jα, and Cα seg-
ments (Figure 1E). This TCR-α location suggested that the higher 
frequency of MAITs found in the CAST strain might be related to 
an increased generation of the iVα19-Jα33 rearrangements.
Since MAITs do not accumulate in the thymus (see ref. 32 and 
below), the increased generation of the iVα19-Jα33 rearrangement 
was consistent with the higher frequency of iVα19 transcripts in 
the thymus of CAST mice in comparison with B6 (Figure 2A). 
This hypothesis is further supported by the strict segregation of 
the iVα19 levels in the thymus of the F2s according to the MAIT 
locus genotype (Figure 2A). To determine whether expression of 
the MAITCAST trait by hematopoietic cells was sufficient to increase 
MAIT frequency, T cell–depleted BM from B6-MAITB6 or B6-MAI-
Figure 1. MAIT abundance in 
mouse is determined by genetic 
background rather than a lim-
ited microbiota. (A) Normalized 
Vα19-Jα33 mRNA levels in the LP 
of the progeny of GF Mr1+ Tap–/– 
Ii–/– breeding pairs reconstituted or 
not with human microbiota. Mr1+ 
or Mr1–/– Tap–/– Ii–/– SPF mice are 
shown as controls. (B) Normal-
ized Vα19-Jα33 mRNA expression 
in the MLNs of B6, PWK, CAST, F1 
(B6 × CAST), and N2 (F1 × B6). (C) 
Manhattan plot of SNP call signifi-
cance (–log
10
[P]) of MAIThi versus 
MAITlo (BC2 or BC3) ordered by 
chromosomal location. (D) Normal-
ized Vα19-Jα33 mRNA expression 
in the MLNs of F2 (F1 × F1) mice, 
grouped by genotype of the MAIThi 
locus: B6/B6, Het, CAST/CAST. (E) 
Genomic map of the chromosome 
14 TCR-α region encompassing the 
MAITCAST locus (boxed).
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Figure 2. The MAITCAST locus determines iVα19 levels in the thymus, is hematopoietic intrinsic, and leads to an increased usage of the distal Vα 
segments. (A) Normalized Vα19-Jα33 mRNA levels in the thymus of the indicated mice. (B) Normalized Vα19-Jα33 mRNA levels in irradiated B6 
recipients 60 days after reconstitution by T cell–depleted BM from B6-MAITB6 (B6) or B6-MAITCAST (CAST) donors. (C) Top: map of the TCR-Vα locus. 
Bottom: Vα segment usage by thymocytes from the indicated mice (mean ± SD) (2–3 individual mice of each genotype were studied). (D) Normalized 
Vα19-Jα33 mRNA levels in the thymus of the indicated mice. (E) The effect of the MAITCAST locus is chromosome 14 intrinsic: the Vα19+ TCR-αs were 
sequenced in thymocytes from F1 (B6 × CAST) mice. Their B6 or CAST origin was determined according to 2 polymorphic nt in the Vα19 segment. B6 
and CAST mice were used as controls.
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Altogether, these results further 
argue against the involvement of dis-
parities in DP thymocyte life span or 
other cell biology processes between 
the 2 strains that would explain the 
high MAIT frequency in CAST mice. 
Differences in the molecular mecha-
nism of the Vα to Jα recombination 
between B6 and CAST strains are 
certainly involved.
Identification and tissue distri-
bution of MAITs in B6-MAITCAST 
congenic mice. The increased number of MAITs in B6-MAITCAST 
congenic mice allowed us to further characterize their tissue dis-
tribution and phenotype. Using RT-qPCR, we quantified MAITs 
in the different organs of B6-MAITCAST mice on an Mr1+ or Mr1neg 
background. In Mr1+ thymus, the amount of iVα19 transcripts was 
higher (23.9 ± 5.5 AU) than in B6 or BALB/c (Figure 2, A and D, 
and Figure 3A). Notably, the iVα19 levels were barely decreased 
on an Mr1neg background, further confirming that MAITs do not 
accumulate in the thymus. In the periphery, MAITs were abun-
dant in the liver, with a strong difference between Mr1+ and Mr1– 
mice (117 ± 62 AU versus 8.1 ± 5.2 AU) (Figure 3A). A similar pat-
tern was observed in the colon LP (53 ± 17 AU versus 5.3 ± 5.2 
AU). The iVα19 levels in the MLNs (14.4 ± 2.7 AU) and spleen (28 
± 9.3 AU) (Figure 3A) were not significantly different from the 
levels observed in the thymus. Nevertheless, the absence of MR1 
expression resulted in slightly lower iVα19 levels in these latter 
(Figure 2D): MAIT iTCR-α frequency was 3.4 ± 0.3 AU in BALB/c 
as compared with 1.03 ± 0.26 in B6 (Figure 2D). Altogether, these 
results suggest that a higher usage of distal Vα segments contrib-
utes to the higher frequency of MAITs observed in CAST mice.
The origin of the higher use of the distal Vα segments in CAST 
is not clear. The mapped region includes part of the 3′ UTR of 
Dad1, a gene with antiapoptotic function (Figure 1E). Because any 
decrease of the life span of the CD4+CD8+ (DP) thymocytes leads 
to a decrease in the use of the Vα19 segment (44), we quantified 
Dad1 mRNA in B6 and CAST mice and observed similar expression 
(Supplemental Figure 2B). We also did not find any differences in 
the recombination signal sequences of the Jα33 segments between 
B6 and CAST (45). Notably, the higher rate of Vα19-Jα33 rear-
rangements found in CAST was chromosome intrinsic. Indeed, 
in B6/CAST F1 thymocytes, more than 80% of the Vα19+ TCR-α 
transcripts were encoded by the CAST chromosome (Figure 2E). 
Figure 3. MAITs in Rorcgt-GFPTG B6-MAI-
TCAST mice are GFP+CD44hiDN/CD8lo. (A) 
Normalized Vα19-Jα33 mRNA expression 
in the indicated organs from Mr1+ or Mr1–/– 
B6-MAITCAST mice. (B) Normalized Vα19-
Jα33 mRNA levels in the indicated subsets 
isolated from pooled spleen and MLNs. 
CD4+ (CD4+CD8–), CD8hi (CD4–CD8hi), DN 
(CD4–CD8lo/neg), total (unseparated), naive 
(CD44lo), and memory (CD44hi) cells are 
shown. Each dot represents an indepen-
dent sort from pools of 2 to 5 mice studied 
in 5 independent experiments. (C) Gating 
strategy and staining (left, liver) and 
frequency (right) in the indicated organs 
of TCR-ȕ+Thy1.2+CD1d-αGC-TetnegGFP+CD4+, 
CD8hi or DN (CD4–CD8lo/neg) cells in Rorcgt-
GFPTG B6-MAITCAST mice. Representative 
of 3 independent experiments with 3 
to 5 mice per group. For skin and lungs, 
6 mice in each group were studied in 1 
experiment. (D) Normalized Vα19-Jα33 
mRNA levels in FACS-sorted TCR-
ȕ+Thy1.2+CD4negCD8lo/negCD44hiGFP+ cells 
(black circles) and GFP– cells (white circles) 
from the MLNs and spleen of Rorcgt-GFPTG 
B6-MAITCAST (CAST/CAST, CAST homo-
zygote; Het, heterozygote; for the MAIT 
locus), Rorcgt-GFPTG B6-MAITB6 (B6/B6), 
or Rorcgt-GFPTG B6 (B6) mice. Each dot 
represents an independent sort from pools 
of 2 to 5 mice.
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organs (8.72 ± 3.7 AU and 7.8 ± 3 AU, respectively). Thus, in mice, 
although MAITs do not significantly accumulate in the periph-
eral lymphoid organs, they are still more abundant in the liver 
and colon, as observed in humans. However, the overall number 
of MAITs in mice was much lower than in humans, suggesting 
that mouse MAITs do not considerably expand in the periphery.
The poor peripheral accumulation might be related to differ-
ences in naive/memory status of mouse versus human MAITs, as 
we have previously observed that MAITs from Vȕ6 Tg and Tap–/– 
Ii–/– mice display a naive (CD44lo) phenotype (32). We therefore 
sorted T cells from the spleen and 
the MLNs of B6-MAITCAST congenic 
mice according to CD4/CD8 and 
CD44 expression and quantified the 
iVα19 transcripts. The iVα19 mRNA 
was found mostly in DN, CD8lo, and 
CD44hi fractions (Figure 3B), indi-
cating that mouse MAITs are CD4neg 
(DN/CD8lo) and display a CD44hi 
memory phenotype as in humans. 
The absence of CD8αȕhi expression by 
mouse MAITs is consistent with the 
CD8αȕlo and CD8αα/DN phenotype 
of human adult MAITs (21, 22, 32).
Until MR1 tetramers become 
widely available, mouse MAIT 
study will remain hampered by the 
lack of specific markers, as there 
is no mouse equivalent to human 
CD161 or another surface marker 
that would be specific for MAITs. 
Because all human MAITs express 
the transcription factor RORȖt (21, 
24), we introgressed a Rorcgt-GFPTG 
reporter Tg (46) into B6-MAITCAST 
congenic mice based on the hypothesis that most GFP+ cells 
in the DN/CD8lo T cell subsets would be MAITs. The number 
of CD44hiGFP+ cells in the CD8hi or CD4+ subsets did not vary 
significantly in Mr1+ versus Mr1–/– backgrounds (Figure 3C). In 
contrast, an MR1-dependent subset of CD44hiGFP+ DN/CD8lo T 
cells was observed in the different organs of B6-MAITCAST mice, 
with higher frequencies in nonlymphoid tissues such as liver, 
lung, skin, and gut LP than in lymphoid organs, including spleen 
and MLNs (Figure 3C).
To verify that CD44hiGFP+DN/CD8lo T cells are mostly MAI-
Figure 4. Development of MAITs after birth 
and TCR-ȕ repertoire analysis of mouse 
MAITs. (A and B) Quantitation of MAITs by 
(A) RT-qPCR or (B) flow cytometry in the 
indicated organs at different time points 
after birth. Dot plots are gated on DNCD8lo 
T cells. (C and D) The indicated mouse cell 
subsets were FACS sorted from Rorcgt-
GFPTG B6-MAITCAST mice, and Vȕ8.1 TCR-ȕ 
repertoire analysis was performed by deep 
sequencing. The cumulative frequency of 
productive TCR-ȕ rearrangement is plotted 
for individual clonotypes ranked according 
to decreasing frequency. (C) Naive (CD62L-
hiCD44lo) and memory (CD62LloCD44hi) CD4+ 
or CD8+ subsets were included as controls. 
(D) Control populations, NKT (CD1d-αGC-
Tet+), and MAIT (CD4negCD8lo/negCD44hiGFP+) 
from the indicated organs were analyzed. 
Two to three (except for the liver) replicates 
were studied for each condition, and 
representative results are shown. Analysis 
of Vȕ8.2 TCR-ȕ segments showed similar 
results (not depicted).
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Ts in Mr1+ Rorcgt-GFPTG B6-MAITCAST mice, iVα19 chain mRNA 
was quantified in spleen T cells from Mr1+ and Mr1–/– mice sorted 
according to GFP, CD44, and CD4/CD8 expression. iVα19 expres-
sion was MR1-dependent and strongly correlated with RORȖt-GFP 
expression (Figure 3D). The level of iVα19 mRNA in GFP-express-
ing CD44hiDN/CD8lo cells from MR1-sufficient B6-MAITCAST 
mice (1783 ± 908 AU) was 90 times higher than in the GFP-neg-
ative counterparts and 280 times higher than in MR1-deficient 
B6-MAITCAST mice (6.4 ± 4.3 AU for GFP+ and 3 ± 1.3 AU for GFP– 
cells) (Figure 3D). This pattern of iVα19 expression also occurs 
in B6-MAITB6 or B6 mice (350-fold higher in CD44hiGFP+DN/
CD8lo T cells from Mr1+ than from Mr1–/– mice) (Figure 3D). The 
iVα19 mRNA levels found in CD44hiGFP+DN/CD8lo T cells from 
Mr1+ Rorcgt-GFPTG B6-MAITCAST mice (1,000 times higher than in 
unseparated MLN cells from B6 mice and 10 times higher than in 
MLN cells from Vȕ6 Tg Tap–/– Ii–/– mice) indicate that 80% to 100% 
of these cells were MAITs. These results show that in mice as in 
humans, most, if not all, MAITs display a CD44hiGFP+ DN/CD8lo 
phenotype.
Expansion versus accumulation of MAITs in mice. In humans, 
MAITs are very few in the thymus and cord blood (21, 22) and 
expand after birth to reach high clonal size (20, 33). To deter-
mine the dynamics of MAITs after birth in mice, we quantified 
the iVα19 transcripts at 6 to 30 days of age in the thymus, spleen, 
and liver of Mr1+ or Mr1–/– Rorcgt-GFPTG B6-MAITCAST mice. In 
the spleen and liver, the MAIT frequency was very low in neo-
nates (day 6) and progressively increased after day 13 to day 17 
(Figure 4A). We did not observe any accumulation of MAITs in 
the thymus, as the difference in iVα19 levels between Mr1+ and 
Mr1–/– mice was less than 2-fold at all time points (Supplemental 
Figure 3 for young and Figure 3A for adult mice). To determine 
whether MAITs appearing in young mice express RORȖt, we 
measured GFPhiCD44hiDN/CD8lo T cell frequency in the spleen 
and liver 14 and 19 days after birth (Figure 4B). The frequency of 
MAITs (GFPhiCD44hiDN/CD8lo T cells) increased by 3- to 4-fold 
between these 2 time points, in accordance with iVα19 mRNA 
quantitation. Together, these results indicate that MAITs do not 
accumulate in the thymus, as previously suggested by the study 
of TCR Tg mice and human thymus (21, 32). After birth and up 
to weaning time, MAIT frequency in the spleen and liver gradu-
ally increased to represent approximately 0.1% and 1% of total 
T cells, respectively (Figure 4B).
The increased frequency of MAITs observed in the liver could 
be related either to peripheral proliferation or to an accumulation 
of MAITs in this organ. In the first hypothesis, the TCR-ȕ reper-
toire should be less diverse than in the second, as the clonal size 
would be higher in the case of proliferation. We therefore ana-
lyzed the diversity of the MAIT TCR-ȕ chains using Vȕ segment–
specific primers in PCRs followed by deep sequencing. The MAIT 
(CD44hiGFP+DN/CD8lo) repertoire was compared with that of 
NKT (CD1d-αGC-Tet+), effector memory (EM) (CD44hiCD62Llo), 
and naive (CD44lo) CD4+or CD8+ T cells. The analysis of the rar-
efaction curves (plots relating the cumulative frequency of indi-
vidual clonotypes ranked by decreasing frequency) of Vȕ8.1+ T 
cells from the spleen and liver showed that, although using specif-
ic Vȕ segments, mouse MAITs harbor a rather diverse repertoire, 
similar in diversity to that of NKT cells, without real oligoclonal-
ity (Figure 4, C and D). Similar data were obtained with a Vȕ8.2-
specific primer (data not shown). Together, these results indicate 
that murine MAITs do not extensively proliferate in the periphery 
and that the higher proportion of MAITs found in the liver is the 
result of accumulation rather than proliferation.
Phenotype and functionality of mouse MAITs. Rorcgt-GFPTG 
B6-MAITCAST mice harbor sufficient numbers of GFP-tagged 
MAITs to enable the analysis of their phenotype and functionality. 
We found that MAITs isolated from the spleen and liver express 
high levels of IL-7Rα (CD127), IL-18Rα, and IL-12Rȕ1 (CD212), 
as their human counterparts do (Figure 5A, Supplemental Figure 
4A, and ref. 21), whereas the IL-2Rȕ (CD122) chain was not detect-
able. A subpopulation of spleen MAITs expressed NKG2D, while 
NK1.1 expression was only found on a subset of MAITs from the 
liver. CD26, a dipeptidase highly expressed by human MAITs, was 
expressed by most mouse MAITs (Figure 5B). CD103 was detected 
on a substantial percentage of spleen MAITs, indicating their tis-
sue tropism. In line with this, mouse MAITs did not express CCR7 
and many are CCR6+. A subpopulation of liver MAITs expressed 
CXCR6. CCR5 expression was not detected. In summary, natu-
rally occurring mouse MAITs are very similar to their human 
counterparts and express several markers distinguishing them 
from conventional T or NKT cells, including RORȖt, IL-18Rα, and 
CCR6.
Importantly, all MAIT (CD44hiGFP+ DN/CD8lo) cells from 
Mr1+ B6-MAITCAST mice expressed the transcription factor 
ZBTB16 (PLZF), as observed in humans (Figure 5C and ref. 31). 
In contrast, ZBTB16 was expressed by only a small proportion 
(approximately 3%) of the Vȕ6/8+ DN T cells found in iVα19 Tg 
mice (Supplemental Figure 4B) despite the fact that more than 
50% of these cells are bacterial reactive and MR1 restricted (6, 
32). These results probably explain the lack of Zbtb16 detection 
by RT-qPCR in our previous report that examined Zbtb16 levels in 
CD8+and DN T cells isolated from iVα19/Vȕ6 double-Tg mice (32). 
In addition, 100% of the GFP+ cells found in the DN T cell subset 
from Vȕ6 Tg B6-MAITCAST mice expressed ZBTB16 (Supplemental 
Figure 4C). These results suggest that the premature expression 
of the iTCR-α chain or saturation of the selecting niches (47) does 
not allow the acquisition of the full MAIT differentiation program 
in TCR Tg mice.
To assess the functionality of mouse MAITs, we sorted them 
together with control populations: mainstream memory (CD44hi) 
CD4+and CD8+ T cells as well as NKT cells (the sorting strategy is 
shown in Supplemental Figure 5). We then assessed the production 
of lymphokines after stimulation with anti-CD3/CD28 beads (Fig-
ure 5D). We found that MAITs produced small amounts of IFN-Ȗ, 
but high levels of TNF-α, GM-CSF, and IL-17. Contrary to human 
MAITs, mouse MAITs secreted measurable amounts of IL-4 and 
IL-10 and low levels of IL-5. This particular lymphokine secretion 
pattern was similar in Vȕ6+, Vȕ6/8+, or Vȕ6– MAITs, suggesting 
that the presence of Th2 cytokines was not due to a contamina-
tion by type 1 NKT cells, which do not express the Vȕ6 segment. 
However, the presence of type 2 NKT cells could not be complete-
ly excluded, since they harbor a diverse TCR-ȕ repertoire and do 
not bind CD1d-αGC tetramers. We therefore repeated this experi-
ment using GFP+CD44+ DN/CD8lo T cells from Cd1d–/– B6-MAI-
TCAST mice that are devoid of any kind of NKT cells. Importantly, 
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lar to that observed in CD1d-sufficient Mr1+ B6-MAITCAST mice, 
excluding the possibility that the Th2 cytokines were produced by 
contaminating NKT cells. Collectively, these data indicate that, 
in addition to Th1/17 type cytokines, mouse MAITs secrete low 
amounts of Th2 cytokines. To determine whether Th1/2/17 cyto-
kines were produced by different MAIT subsets or concurrently 
secreted by a single MAIT, we analyzed IFN-Ȗ, IL-4, and IL-17 
the frequency of GFP+CD44+ DN/CD8lo T cells in Cd1d–/– Mr1–/– 
B6-MAITCAST mice was extremely low (Supplemental Figure 6, A 
and B), indicating that more than 90% to 95% of the GFP+ CD44+ 
DN/CD8lo T cells found in Cd1d–/– Mr1+ B6-MAITCAST mice are MR1 
dependent. MAITs from Cd1d–/– Mr1+ B6-MAITCAST mice displayed 
a pattern of lymphokine secretion (low IFN-Ȗ, high IL-17, and mea-
surable levels of IL-4 and IL-10; Supplemental Figure 6C) simi-
Figure 5. Phenotype and cytokine production by 
mouse MAITs. (A and B) Surface expression of the 
indicated markers was analyzed on Thy1.2+TCR-ȕ+ T 
cells from the (A) spleen or (B) liver of Rorcgt-GFPTG 
B6-MAITCAST mice. The indicated subsets were studied: 
MAITs (DN/CD8loCD44+GFP+), memory CD8+ T cells 
(CD8hiCD44+), and NKT cells (CD1d-αGC-Tet+). Shaded 
histograms show isotype or FMO control (CD103). 
Representative of at least 3 experiments. (C) Expres-
sion of PLZF and RORȖt-GFP by DN/CD8loCD1d-αGC-
Tet– TCR-ȕ+ T cells from Mr1+/+ or Mr1–/– Rorcgt-GFPTG 
B6-MAITCAST mice. (D) Cytokine secretion by MAITs in 
comparison with control populations. T cells from the 
spleen of Rorcgt-GFPTG B6-MAITCAST mice were identi-
fied as Thy1.2+TCR-ȕ+ cells, and memory (CD44+) CD4+ or 
CD8+, MAIT (DN/CD8loCD44+GFP+), and NKT (CD1d-α-
GC-Tet+) subsets were FACS sorted. Eight-thousand 
cells from each sorted T cell subset were cultured with 
anti-CD3/28 beads (1:1) for 42 to 45 hours and the 
cytokine content measured in the culture supernatant. 
The results were derived from 4 to 7 separate cultures 
collected over 3 independent experiments. Each dot rep-
resents an individual sort. Dashed line indicates quanti-
tation limit. Dots on the x axis indicate not detected.
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CD8+ T cells from the same 
culture dish, were specifically 
activated by the SPB fraction, 
as shown by the upregulation 
of the activation markers CD69 
and CD25 (Figure 6, A and B). 
This activation was MR1 depen-
dent, since it was blocked by an anti-MR1 antibody (Figure 6, A 
and B). In line with this, incubation of the SPB fraction with the 
parental WT3 cell line (which expresses very low levels of MR1) 
did not activate MAITs. The active compound or compounds in 
this bacterial fraction derive from the rib biosynthesis pathway 
(10, 49) through a reaction between the rib intermediate 5-amino-
6-D-ribityl-uracil (5-A-RU) and methyl-glyoxal (MeG) generating 
the 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-
RU) pyrimidine adduct. The 5-OP-RU binds to and is stabilized by 
MR1 and activates MAITs. We therefore measured the activation 
of polyclonal MAITs by MR1-overexpressing WT3 cells incubated 
with serial dilutions of 5-A-RU extemporaneously mixed with 
MeG. MAITs were activated by this compound when incubated 
with MR1-overexpressing cells but not the MR1lo parental cell 
line (Figure 6C). The activation was also decreased in the pres-
ence of an anti-MR1 antibody. These results demonstrate that the 
GFP+CD44hiDN/CD8lo T cells found in Mr1+ B6-MAITCAST mice 
are bona fide MAITs, recognizing a bacterial ligand derived from 
the rib biosynthesis pathway in an MR1-dependent manner.
Polyclonal mouse MAITs are protective and migrate to the 
infection site in an experimental model of UTI. The availability of 
a MAIT-rich mouse model allowed us to investigate the role of 
MAITs in antimicrobial immunity. Because we detected MAITs 
in the urine of 10 out of 12 patients with leukocyturia associated 
with UTI (Figure 7, A and B), we studied an experimental model 
of UTI. Female Rorcgt-GFPTG B6-MAITCAST mice with (Mr1+) or 
without MAITs (Mr1–/–) were intravesically instilled with uro-
expression by intracytoplasmic staining of splenocytes after sever-
al stimulations, namely, anti-CD3/CD28 beads, PMA/ionomycin, 
or paraformaldehyde-fixed (PFA-fixed) E. coli (Supplemental Fig-
ure 7). PMA/ionomycin or TCR ligation induced substantial IL-17 
expression by MAITs, while IFN-Ȗ and IL-4 were undetectable, 
in line with the recently published results of cytokine production 
by MAITs from B6 mice identified with MR1-5-OP-RU tetramers 
(48). Interestingly, IFN-Ȗ was detected in MAITs only after activa-
tion with E. coli, suggesting that MAITs require additional innate 
signals to efficiently produce IFN-Ȗ. Whether Th1/2/17 cytokines 
are produced by different MAIT subsets remains to be addressed, 
since we have been unable to define stimulation conditions in 
which all the cytokines are reliably detectable by intracytoplasmic 
staining.
To determine whether the presence of MAITs influences anti-
body production, we measured the serum levels of IgA and IgG 
isotypes in Mr1+ and Mr1– B6-MAITCAST mice (Supplemental Fig-
ure 8). Serum IgA levels were slightly decreased in the absence of 
MAITs, but the levels of all the other Ig isotypes tested were simi-
lar. These results suggest that MAITs are probably not involved 
in the regulation of systemic humoral responses, but may modify 
local immune responses.
To further verify the antigen specificity of GFP+CD44hiDN/
CD8lo T cells, we measured their activation after stimulation with 
graded amounts of a MAIT-activating semipurified bacterial frac-
tion (SPB) (49) loaded on MR1-overexpressing WT3 cells (50). We 
found that MAITs (GFP+CD44hiDN/CD8lo), but not GFPloCD44hi 
Figure 6. Natural MAITs are 
activated by bacteria-derived 
compound in an MR1-dependent 
manner. (A) Activation of Rorcgt-
GFPTG B6-MAITCAST splenocytes after 
overnight coculture with SPB (2 
AU) and WT3 cells overexpressing 
MR1 (WT3.mMR1) or the parental 
cell line (WT3). (B) Dose-response 
curves of MAIT activation in the 
presence or absence of anti-MR1 
(26.5) blocking antibody. The results 
were pooled from 3 independent 
experiments (mean ± SD). (C) Acti-
vation of Rorcgt-GFPTG B6-MAITCAST 
splenocytes with 0.93 μM of 5-A-RU 
extemporaneously mixed with MeG 
(1:1 ratio) after overnight incuba-
tion with WT3 or WT3.mMR1 cells 
together with anti-MR1 antibdody 
(bottom panel). (D) Dose-response 
curves of MAIT activation in the 
presence or absence of anti-MR1 
blocking antibody. Results rep-
resent a pool of 3 mice. (C and D) 
Representative of 2 independent 
experiments.
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lation of T cells in the bladder upon infection, we also detected 
an increase in the absolute number of GFP+CD44hiDN/CD8lo T 
cells in Mr1neg mice, but this was always substantially lower than 
in Mr1+ littermates. To investigate the antibacterial activity of 
the infiltrating MAITs, we assessed the bacterial load in infected 
bladders at different time points. The presence of MAIT in the 
bladders of Mr1+ B6-MAITCAST mice was associated with more 
efficient bacterial clearance than in Mr1–/– littermates (Figure 
pathogenic E. coli (UPEC) strain UTI89 (51). The lymphoid 
cells infiltrating the bladder were analyzed by flow cytometry. 
We observed robust recruitment of αȕT cells (Figure 7, C and 
D), including CD4+ conventional T cells (Figure 7E) and MAITs 
(Figure 7F), starting 2 days after infection. Indeed, a significant 
increase in GFP+CD44hiDN/CD8lo T cell numbers was detected 
in the infected bladders of Mr1+ mice at day 2 and was sustained 
for at least 7 days (Figure 7F). As we observed an overall accumu-
Figure 7. MAITs are recruited to the bladder upon UTI in humans and mice and contribute to bacterial clearance in mice. (A) Gating strategy on TCR-
Ȗδ–CD3+ T cells isolated from urine samples collected from patients with UTI. (B) Enumeration of MAITs in the urine: number of T lymphocytes (TL) (left 
panel) and MAITs (right panel) per ml of urine. (C) Flow cytometry analysis of T cells infiltrating bladder from Mr1+ or Mr1–/– Rorcgt-GFPTG B6-MAITCAST mice 
at day 0 (naive) or 2 or 7 days after infection with UTI89. Representative FACS plots and gating strategy are shown. Numbers in parentheses correspond to 
total number of cells. (D–F) Quantitation of bladder-infiltrating total T cells (D), CD4+ T cells (E), and MAITs (F) at the indicated time points post infection 
(p.i.). (G) UTI89 bacterial load in mouse bladders at indicated time points. Pooled data from 2 to 3 independent experiments. *P < 0.05; **P < 0.01; ***P < 
0.001.
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etic (Figure 2B) intrinsic and was already observed in the thymus 
(Figure 2A). The small difference in MAIT frequency found in the 
thymus of Mr1+ versus Mr1–/– animals (Figure 3A) is consistent with 
the absence of MAIT accumulation in this organ (32). Indeed, the 
occurrence of the restricting MHC allele during thymic selection 
has a small impact on the frequency of naive T cells specific for 
many nominal antigens (52).
The lower frequency of iVα19+ cells in the periphery of Mr1–/– 
in comparison with Mr1+ animals suggests that MR1 expression 
in the periphery is necessary for their activation and/or their 
peripheral expansion and survival. Nevertheless, the peripheral 
expansion in mice is much lower than in humans, as indicated 
by the diverse MAIT TCR repertoire in the liver of B6-MAITCAST 
mice, which suggests that MAITs accumulate rather than prolifer-
ate in this organ. We also observed that both NKT and EM T cells 
expanded less in the SPF mice we studied than in humans (Figure 
4 and refs. 20, 53). This might be a general difference of effector 
cells between the 2 species and would suggest that the turnover of 
NKT and MAITs is slower in humans than in mice.
The smaller number of MAITs in SPF B6-MAITCAST mice in 
comparison with humans might be related to differences in the gut 
microbiota between these 2 species. Although the similar number 
of MAITs in the LP of SPF mice and germ-free mice colonized by 
human microbiota (Figure 1A) argues against this hypothesis, it 
remains to be determined whether MAIT numbers would increase 
after implantation of human microbiota into B6-MAITCAST mice. 
Although the proportion of type 2 NKT is higher in humans, NKT 
cells are much more abundant in mice than in humans. Therefore, 
a competition between MAIT and NKT cells during intrathymic 
development or for peripheral niches could also be involved. How-
ever, NKT cell numbers were not increased in the spleen, MLNs, 
liver, and LP of Mr1–/– mice (data not shown), while MAITs were 
only slightly increased in Cd1d–/– B6-MAITCAST mice (Supplemen-
tal Figure 6), arguing against this hypothesis.
In the absence of available MR1 tetramers or anti-Vα19 anti-
body, we relied on RT-qPCR of the iVα19-Jα33 iTCR-α chain to track 
MAITs. The iTCR-α chain was only found in the CD44hiCD8loDN 
subset (Figure 3B), confirming that mouse MAITs are not found in 
the CD4+ or CD8hi subset, as observed in humans. Similarly to what 
occurs in humans, MAITs were mostly found in tissues such as liver 
and colon LP (Figure 3A). To facilitate phenotype analysis and allow 
functional studies, we introgressed an Rorcgt-GFP reporter into the 
B6-MAITCAST congenic strain. Almost all CD44hiGFP+CD8loDN T 
cells in adult B6-MAITCAST mice expressed the iVα19-Jα33 TCR-α 
chain (Figure 3D). However, since this subset might also encom-
pass a few CD1d-restricted NKT cells, we verified our lymphokine 
secretion studies using MAITs from Cd1d–/– Rorcgt-GFPTG B6-MAI-
TCAST mice. Overall, with regard to phenotypic features, mouse 
MAITs are similar to human ones, assuming that mouse DN/CD8lo 
T cells are orthologous to human DN/CD8αα and CD8αȕlo T cells. 
The presence of IL-18Rα and IL-12Rȕ1 indicates that mouse MAITs 
can be activated by innate signals, as are human MAITs (25).
Although MAITs were discovered by identifying an iTCR-α chain 
in a particular T cell subset (20), in our opinion, MAITs should be 
defined as T cells educated by MR1 in the thymus to acquire a specif-
ic differentiation program. Whether MR1-restricted T cells are limit-
ed to T cells expressing iVα19-Jα33 iTCR-α (and iVα7.2-Jα33/12/20 in 
7G). Furthermore, a sustained presence of MAITs during the late 
phase of infection (day 7) correlated with lower numbers of con-
ventional T cells in infected bladders, suggesting more efficient 
resolution of the inflammation and the potential to enhance the 
subsequent adaptive immune response, although we did not 
study this directly. These data indicate that MAITs are present in 
the bladder and display protective antimicrobial activity.
Discussion
Although MAIT frequency is modified in several diseases, the 
role of MAITs in health and disease is still elusive, as no clear 
evidence associates them with a specific pathology. This can 
be addressed by studying animal models, but the number of 
MAITs in SPF-raised conventional laboratory mice is close to 
the detection limits. Tg mice for the TCR-α or TCR-ȕ chains of 
MAITs are very useful for assessing MAIT reactivity and also to 
some extent for the study of MAIT selection (32, 36). However, 
the use of TCR Tg mice for functional studies is more challeng-
ing because the premature overexpression of the iTCR-α chain 
leads to artifactual features (41). These caveats are difficult to 
overcome even with the comparison to an Mr1neg control, as dis-
cussed in the supplementary text of ref. 32. On the other hand, 
for the available TCR-ȕ Tg mice (Vȕ6 and Vȕ8), both chains were 
isolated from iVα19+ T-T hybridoma recognizing MR1-overex-
pressing fibroblastic cell lines. Therefore, the potential for auto-
reactivity of these TCRs against MR1 itself or MR1 loaded with 
a culture medium component cannot be excluded. Whether this 
putative autoreactivity affects the selection and functions of the 
T cells found in these Tg mice is currently being studied.
Given the high conservation between species of both the 
restricting element MR1 and the iTCR-α chain, the disparity 
between the number of MAITs in humans and laboratory mice is 
intriguing. Although it was recently shown that MAITs can tremen-
dously expand in B6 mice during bacterial infection by Francisella 
tularensis and display protective activity after depletion of conven-
tional T cells (8), it is rather difficult to envision how such a minor 
subset would drive innate-like response and display protection 
during natural infection or infections in unmanipulated settings. 
We set out to understand the reasons for this apparent paradox. 
Because the reconstitution of germ-free mice with human micro-
biota did not lead to higher frequency of MAITs than that found in 
SPF mice, we hypothesized that laboratory mice may have lost an 
allele or alleles important for the defense against common patho-
gens due to the absence of selection pressures in the clean animal 
facilities. Indeed, laboratory mice are not representative of the 
existing mouse species, as they harbor less than 25% of the genetic 
diversity of wild mice (45).
We found 2 wild-derived inbred SPF mouse strains with higher 
frequency of MAITs. Given the naive phenotype of MAITs we had 
observed in iTCR-α Tg mice, we expected that the gene or genes 
involved in the MAIThi phenotype would be implicated in the acti-
vation, survival, and/or expansion of MAITs. To our surprise, the 
20-fold increase in MAIT frequency found in the CAST strain was 
linked to 1 locus located at the 3′ end of the TCR-α region, leading 
to higher production of the specific rearrangement. Although the 
exact molecular mechanism is not elucidated, the increased num-
ber of MAITs was CAST chromosome (Figure 2E) and hematopoi-
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conventional T cell accumulation or survival. Therefore, this model 
will be very useful to study, for instance, the mechanisms of bacillus 
Calmette-Guérin (BCG) antitumor activity during the treatment of 
bladder carcinoma (57). This MAIT-rich mouse model will also allow 
the test of MAIT stimulation with synthetic ligand as a therapeutic 
tool in various diseases or as an adjuvant for vaccine development.
Methods
Mice. B6 mice were obtained from Charles Rivers Laboratories. The 
Mus musculus castaneus (CAST/EiJ) and Mus musculus musculus PWK 
strains were provided by X. Montagutelli (Institut Pasteur). The Rorc-
gt-GFPTG (46) and Cd1d–/– lines, both on a B6 background, were provid-
ed by G. Eberl (Institut Pasteur) and A. Lehuen (INSERM U1016, Insti-
tut Cochin, Paris, France), respectively. The 3 strains were transferred 
as embryos into our animal facility at Institut Curie. Tap–/– Ii–/– Mr1+ 
(and Mr1–/–) mice have been previously described (32). B6-MAITCAST 
congenic mice were obtained by selecting mice expressing a MAIThi 
phenotype in the blood to be bred to B6 mice for more than 10 genera-
tions.
Germ-free Tap–/– Ii–/– mice were obtained by Cesarean section at 
the CNRS Central Animal Facility (Orléans, France) and then housed 
at the ANAXEM Animal Facility, INRA (Jouy-en-Josas, France). The 
reconstitution with human microbiota was carried out at INRA. Colo-
nization was verified several times during the experiments. At 2 to 3 
months after reconstitution, colon LP lymphocytes were collected and 
MAITs were quantified by real-time RT-qPCR.
Mouse cell preparation. Thymus, spleen, and MLNs were col-
lected into cold PBS with 0.5% BSA. Lymphocytes were liberated 
by mechanical disruption over a cell strainer. Livers and lungs were 
perfused with 10 ml of PBS to remove circulating blood cells. Livers 
were then dissociated by passing through a 100-μm cell strainer and 
resuspended in PBS with 0.5% BSA. Lung lobes and chopped skins 
were digested in CO
2
-independent media containing 0.5 Wünsch 
units/ml liberase (Roche) and 0.1 mg/ml DNase I (Roche) at 37°C 
for 30 minutes (lung) to 1 hour (skin) and further dissociated using 
gentleMACS Dissociator according to the manufacturer’s instruc-
tions (Miltenyi Biotec). The cell suspensions were filtered through 
a 100-μm cell strainer. The released cells from liver, lung, and skin 
were layered on a 40%/80% Percoll gradient (GE Healthcare) and 
spun at 800 g for 20 minutes at room temperature. Mononuclear 
cells were recovered from the interface. Intestinal lymphocytes were 
isolated as previously described (20, 57, 58). Briefly, large intestines 
were collected in cold PBS. The intestines were carefully flushed 
and opened longitudinally. Intestinal epithelium was removed by 
shaking in 60 ml of PBS with 3 mM EDTA for 10 minutes (twice) 
followed by 15 minutes incubation in 15 ml of CO
2
-independent 
medium containing 1.5 mM MgCl
2
 and 1 mM EGTA (twice) at 37°C. 
The remaining tissue was cut into 1- to 2-mm pieces and digested in 
30 ml of CO
2
-independent medium containing 20% FCS, 100 U/ml 
collagenase (type VIII, Sigma-Aldrich), and 5 U/ml DNase I (DN25, 
Sigma-Aldrich) and shaken for 90 minutes at 37°C. The tissue sus-
pension was dissociated by syringe aspirations and passed through 
a cell strainer. Cell suspension was pelleted followed by density 
gradient centrifuge at 1,000 g for 25 minutes at room temperature 
(lympholyte; Cedarlane). LPLs were recovered from the interface.
Cells were cultured in DMEM or RPMI 1640 medium supple-
mented with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 μg/
humans, ref. 38) is not yet clear. The data above indicate that if other 
MR1 restricted T cells with a distinct repertoire exist, they would 
have to be distinct from the CD44hiRORȖt+CD8loDN subset. In addi-
tion, it remains to be determined whether all MR1-restricted T cells 
would be labeled with MR1 tetramers loaded with one given ligand. 
This is true for adult human MAITs (38). In humans, the presence in 
the cord blood of T cells expressing high levels of CD161hiIL-18Rα+ 
(22) that are not Vα7.2+ suggests that T cells with a distinct repertoire 
can follow a development pathway similar to that of MAITs (54), 
probably linked to the selection on DP thymocytes (55). Whether all 
these T cells are MR1 restricted remains to be determined. (22, 56)
In Mr1+ iVα19 Tg Ca–/– mice, we observed that most CD4+ 
T cells are neither bacterial reactive nor MR1 restricted (6, 32). 
In contrast, a significant number of MR1-dependent MR1-Tet+ 
Vȕ6/8.1-2+ T cells were CD4+ in another iVα19 Tg line (38). In the 
current study, in a polyclonal model, in the organs we studied, we 
did not observe CD4+ MR1-restricted T cells, confirming our pre-
vious reports (6, 32). The origin of these discrepancies between 
different iVα19 Tg Ca–/– lines might be due to differences in the 
microbiota of the animal facilities or TCR-α Tg timing or level 
of expression. Nevertheless, the polyclonal B6-MAITCAST mouse 
model described herein is not subjected to this TCR Tg artifact 
and largely recapitulates the features of human MAITs.
This new model allowed us to study the phenotype and func-
tion of MAITs in mice. Our results are concordant with the MR1-5-
OP-RU tetramer–based characterization of the rare MAITs found 
in C57BL/6 mice that has recently been published (48) and con-
firm the interest of the Rorcgt-GFPTG B6-MAITCAST mouse strain. 
Overall, mouse and human MAITs were very similar with regard to 
phenotype and lymphokine secretion (21).The few differences we 
observed were a more diverse repertoire related to a lower periph-
eral expansion, low CXCR6 expression, and secretion of IL-4 and 
IL-10. We (21) and others (25, 26, 30) have never observed such 
a lymphokine secretion pattern in humans. The impact of MAITs 
on antibacterial mucosal IgA responses suggested by the slight-
ly lower level of serum IgA will be addressed in further studies. 
Importantly, like human MAITs, polyclonal mouse MAITs from 
B6-MAITCAST mice expressed both ZBTB16 and RORȖt transcrip-
tion factors in contrast to our study on iVα19-Vȕ6 double-Tg mice 
(32). The changes in T cell ontogeny imparted by the premature 
expression of a TCR-α Tg probably explain these differences.
The origins of the differences between mouse and human 
MAITs are unclear. With regard to repertoire, all the memory T 
cell subsets, whether innate-like or conventional effector, seem to 
display lower oligoclonality in mice in comparison with humans 
(Figure 4B and refs. 20, 33). Thus, MAITs would be similar to oth-
er memory subsets in mice. However, it should be stressed that, 
in humans, only blood MAITs were studied, whereas the mouse 
MAITs were isolated from lymphoid organs or tissues.
The availability of a mouse model harboring polyclonal MAITs 
allowed us to study their putative involvement during an experi-
mental UTI. In line with the human data (Figure 7A), we observed 
the presence of MAITs in the mouse bladder during UTI. Moreover, 
MR1-deficient mice exhibited higher bacterial load, in particular at 
late time points (Figure 7G). The larger conventional T cell infiltra-
tion in the bladder during infection in the absence of MAITs may 
be related to higher bacterial load or to a direct effect of MAITs on 
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MAIT stimulation with bacteria-derived compound. The prepara-
tion of the SPB was previously described (49). Briefly, the bacterial 
lysate was prepared by growing E. coli, DH5α ATCC strain, to satura-
tion. The bacteria pellet was resuspended in water at 4°C for a week 
to induce the release of the MAIT ligand. Supernatant was collected, 
filtered, and phenol-cloroform extracted before being aliquoted and 
lyophilized for further use. One AU corresponds to 25 μl bacterial 
supernatant. 5-A-RU synthesis and 5-OP-RU preparation have been 
described elsewhere (49).
Splenocytes from Rorcgt-GFPTG B6-MAITCAST mice were depleted 
of APCs and CD4+ T cells using anti-CD19, anti-CD11c, anti-CD11b, 
and anti-CD4 MicroBeads (Miltenyi Biotech). Then 3 × 105 MAIT-
enriched splenocytes were cultured with 105 WT3 or mouse MR1–
transfected WT3 (WT3.mMR1) cells (50) that had been preincubated 
with serial dilutions of semipurified bacterial supernatant or 5-A-RU 
plus MeG for 30 minutes at 37°C. Under some conditions, 10 μg/ml 
of anti-MR1 blocking Ab (clone 26.5; ref. 61), provided by T. Hansen 
(Washington University, St. Louis, Missouri, USA), was added before 
adding the T cells. After overnight culture, activation was analyzed 
using flow cytometry.
UTI. Urine samples from patients with UTI were obtained from 
the Microbiology Department of Curie Institute after cytobacterio-
logic analysis. Samples that tested positive for both bacteria and leu-
kocytes were included in the study.
For the experimental UTI, clinical UPEC, cystitis isolate UTI89, 
was grown statically for 20 hours in LB broth, washed in PBS, and 
resuspended for use at 1 to 2 × 107 CFUs per 50 μl (62). Seven- to 
ten-week-old B6-MAITCAST female mice were anesthetized with ket-
amine (125 mg/kg) and xylazine (12.5 mg/kg) intraperitoneally, and 
a 24-gauge catheter (BD Insyte Autoguard, BD) containing either PBS 
or UTI89 was inserted through the urethra; 50 μl of bacterial suspen-
sion or PBS was instilled at a slow rate to avoid vesicoureteral reflux.
At indicated time points, bladders, spleens, and bladder-draining 
LNs were harvested. Bladder-infiltrating lymphocytes were isolated 
from tissue digested in CO
2
-independent medium (Invitrogen) con-
taining Liberase TM (0.17 U/ml) (Roche), collagenase D (1 mg/ml) 
(Roche), and deoxyribonuclease 1 (1 U/ml) (Invitrogen). After 40 
minutes incubation at 37°C in a shaking incubator, tissue suspensions 
were pressed through a 40-μm cell strainer (Falcon), washed in PBS 
with 0.5% BSA and 2 mM EDTA, and pelleted for FACS staining
Quantitative PCR and SNP genotyping. Real-time qPCR was per-
formed as previously described (20). The primers were specific for 
regions that are identical in B6 and CAST strains. Real-time PCR was 
performed using a LightCycler 480 (Roche). Fold change in expres-
sion was determined by the 2-ΔΔCT method after normalizing to the 
TCR-α constant region (Cα).
SNP genotyping assays were custom designed using TaqMan Assay 
Design Tool (Life Technologies) on the reference assembly NCBI37/
mm9. SNP queries were performed using the Mouse Genomes Project 
database (http://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-
1505) and the UCSC Genome Browser (http://genome.ucsc.edu/cgi-
bin/hgGateway).
Statistics. All data were analyzed with the 2-tailed nonparametric 
Mann-Whitney U test using GraphPad Prism v5.0c (GraphPad Soft-
ware Inc.). Data were considered significant at a P value of less than 
0.05. All data are reported as the arithmetic or geometric mean ± SD 
as appropriate.
ml streptomycin, 2 mM L-glutamine, 10 mM HEPES, and 1 mM sodi-
um pyruvate (Gibco; Thermo Fisher Scientific).
Hematopoietic chimera. Donor BM was flushed from tibia and 
femur of 2 B6-MAITCAST or B6-MAITB6 Mr1+ Rorcgt-GFPTG mice. T cells 
were depleted using autoMACS Pro (Miltenyi) after labeling with anti-
CD3 microbeads. Two million T cell–depleted BM cells from either 
donor group were injected into the tail veins of 4 to 5 irradiated CD45.1 
recipients (1.2 Gys). Two months after reconstitution, mice were sacri-
ficed and organs were collected for FACS and RT-qPCR analysis.
Mouse Universal Genotyping Array. DNA was extracted from ear 
punches of 35 MAITlo and 31 MAIThi mice using the Wizard SV Genomic 
DNA Purification System according to the manufacturer’s instructions 
(Promega). DNA was then sent to GenSeek (Neogen) for genotyping 
using the Mouse Universal Genotyping Array (MUGA) chip. Genotyping 
data were analyzed using an in-house R script. Briefly, MUGA data were 
filtered for both sample call rate (≥0.90) and SNP call frequency (≥0.90). 
A Wilcoxon test was performed to compare heterozygosity at each SNP’s 
location according to MAITlo and MAIThi groups. Then P values were –
log10 transformed and plotted according to chromosomal location.
Mouse TCR-α and TCR-β repertoire analysis. TCR-α repertoire study 
was performed using a 5′ rapid amplification of cDNA end adapted to 
deep sequencing using an Ion PGM system (Life Technologies, Ion 
318 Chip vx; 400 base reads) as described previously (42). TCR-ȕ rep-
ertoire was analyzed using Vȕ-specific primers and Cȕ primers that 
included CS1 and CS2 sequences at their 5′ end to enable Illumina 
Sequencing. TCR-ȕ repertoires were obtained by sequencing using 
MiSeq (Illumina, v3 kit; 2 × 300 bases paired-end reads, ICGEX plat-
form). Each data set was demultiplexed and trimmed for base qual-
ity (>25) and read length (>250 bp). Paired reads were merged using 
the flash v1.2.10 program (-m30-M135-t10-x0.1) (59). The data have 
been deposited in the NCBI’s Sequence Read Archive (SRA) database 
(SRR2218429-SRR2218460). Resulting fasta files were then uploaded 
onto the IMGT/high V-Quest webserver (60) (allele*01 only), and the 
Junction file was parsed using an in-house R script to extract informa-
tion regarding the V-J combination and the CDR3 nucleotide compo-
sition. Only predicted productive TCR rearrangements were kept for 
downstream analysis. The TCR-α and TCR-ȕ repertoire sequencing 
data were analyzed using R and vegan packages. To normalize for 
uneven numbers of reads, each data set was subsampled 100 times at 
a depth of 5,000 reads. Then an average rarefaction matrix was com-
puted from the 100 subsampled tables to draw the rarefaction plots.
Flow cytometry. Flow cytometry was performed with directly con-
jugated antibodies according to standard techniques and analyzed on 
FACSAria, Fortessa, and LSRII flow cytometers (BD). DAPI and a 405-
nm excitation were used to exclude dead cells. The list of antibodies is 
available in the Supplemental Methods section.
For transcription factor staining, cells were incubated with the LIVE/
DEAD fixable violet stain (Life Technologies) and Fc block antibody 
prior to cell-surface marker staining. Cells were then fixed and permea-
bilized overnight using the BD Cytofix/Cytoperm kit (BD), after which 
they were incubated with either anti-PLZF or anti-RORȖt antibody
For the detection of cytokines, 8,000 (Figure 5D) or 30,000 
(Supplemental Figure 6C) sorted splenocytes were cultured in 50 μl 
RPMI 1640 complete medium in the presence of anti-CD3/CD28 
Dynabeads (1:1; Gibco, Thermo Fisher Scientific) for 42 to 45 hours at 
37°C. Cytokines in the supernatant were detected using the Cytomet-
ric Bead Array Flex Set (BD Biosciences).
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Fig. S1. Human microbiota reconstitution of breeding TAP Ii double KO mice. (A) Microbiota 
composition at the family level inferred for human replicates (H), SPF mice (SPF) and breeding 
mice reconstituted with human microbiota (F) before (F1-PRW) and after weaning (F1-POW) of the 
pups and mothers (FO). (B) Between class analysis (BCA) computed with the principal 
components analysis of the whole microbiota composition dataset and constrained with H, SPF 
and F instrumental variables.
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Fig. S3. No accumulation of MAIT cells in the thymus after birth. 
Vα19-Jα33 transcripts were quantified by RT-qPCR at the indicated 
time points after birth.
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Figure. S6
Fig. S6. Frequency and cytokine secretion pattern of MAIT cells in CD1d-/- ROR(γt)-GfpTG B6-
MAITCAST mice. Gating strategy and staining (A)  and frequency (B) of TCRβ+Thy1.2+ 
CD4negCD8lo/negGFP+ cells in CD1d-/- Rorc(γt)-GfpTG-B6-MAITCAST mice. Compilation of 3 
independent experiments. (C) Cytokine secretion of the indicated subsets isolated from CD1d-/- or 
WT (Rorc(γt)-GfpTG-B6-MAITCAST) mice as described in Fig. S5. NKT cells were sorted from WT 
mice using CD1d-α-GC tetramer. Compilation of 2 independent experiments.
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Figure. S7
Figure S7. Cytokine production by mouse MAIT cells. Splenocytes from 
CD1d-/- Rorc(γt)-GfpTG-B6-MAITCAST mice were stimulated with anti-CD3/CD28 
beads (9 h), PMA/Ionomycin (5 h), or PFA fixed E.coli (overnight, lower panel) 
and stained for intracellular IL-17A and IFN-γ. Representative plots from three 
independent experiments are shown gating on TCRβ+DN/CD8loCD44+GFP+ cells. 
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Figure S8 
 
Figure S8. In the absence of MAIT cells, serum immunoglobulin isotype levels 
remain unchanged. ELISA was used to measure total IgM, IgG2a, IgG2b, IgG3 and 
IgA in sera drawn from the indicated unchallenged 7-9 week old mice. Bars indicate 
mean ± SD. 
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Cui et al supplementary materials and methods 
Antibody list 
All Abs were purchased from BioLegend, BD Pharmingen, eBioscience unless 
otherwise stated. The antibody clones used included: CD19 (1D3), TCRβ (H57-597), 
CD90.2 (53-2.1, 30-H12), CD4 (RM4-5), CD8 (53-6.7), CD44 (IM7), CD62L (MEL-
14), CD25 (PC61), CD69 (H1.2F3), mCD1d-α-GC tetramers (ProImmune), IL-
7Rα (A7R34), IL-18Rα (BG/IL18RA), IL-12Rβ (114), IL-2Rb (TM-Beta 1), NKG2D 
(CX5), NK1.1 (PK136), CD26 (H194-112), CD103 (2E7), CCR5 (HM-CCR5), 
CCR6 (29-2L17), CXCR6 (221002, R&D systems), CCR7 (4B12), PLZF 
(Mags.21F7), RORγt (AFKJS-9), IL-17A (TC11-18H10.1), IFN-γ (XMG1.2), IL-4 
(11B11).  
In vitro stimulation  
E.coli were cultured overnight at 37°C in Luria Broth, pelleted and washed in PBS 
before fixation for 20 min in 1% of PFA. For intracellular cytokine staining, 2 x 106 
splenocytes were stimulated with 10 ng/ml PMA (Sigma) and 1 µg/ml ionomycin 
(Sigma) for 5 h, anti-CD3/CD28 Dynabeads (1:1, Gibco) for 9 h or fixed E.coli 
overnight. Golgi Plug (1 µg/ml, BD) was added for the final 3-4 h of culture. Prior to 
surface marker staining, cells were incubated with live/dead violet fixable cell stain 
(Life Technologies) and Fc block. Cells were then fixed and permeabilized for 20 min 
using Cytofix/Cytoperm kit (BD) and subjected to intracellular IFN-γ, IL-4 and IL-
17A staining.  
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ELISA 
Blood samples were collected by retro-orbital bleeding from naïve B6-MAITCAST 
MR1+ or MR1-/- mice (n=13 for each genotype, 7-9 weeks old). Total serum IgM, 
IgG1, IgG2a, IgG2b, IgG3 and IgA titers were determined using Ready-Set-Go® 
ELISA kits, according to the manufacturer’s instructions (eBioscience). Data were 
analyzed using second-order polynomial model (Prism GarphPad 5.0) and plotted as 
concentration.  
Fecal samples 
DNA was extracted from stool as previously published (1, 2). DNA quality and 
quantity were checked using NanoDrop and Qubit together with BR assay. 
16S rDNA Barcoding PCR 
Barcoded PCR was carried out using barcoded primers targeting V4-V5 variable 
part of the 16S rRNA gene. iProof High fidelity master mix (Bio-Rad) was used to 
perform the PCR following manufacturer’s recommendations. Mix for one PCR 
reaction was made up of 12.5 µL of iProof High fidelity master mix, 0.5 µL of both 
563F and 924R primers (0.2 µM), 10 µL of RNase DNase free water and 1.5 µL of 
DNA (10 ng). The PCR program applied was 95°C for 5 min followed by 30 cycles 
(95°C for min, 41°C for min and 72°C for min) and a final step at 72°C for min. PCR 
reactions (25 µL) were then quantified using Qubit BR DNA assay kit. Equal amount 
of amplicon DNA were pooled and thoroughly mixed. The resulting amplicon pool 
was loaded on an agarose gel (1.5%) and electrophoresis run for 45 min at 100 V. The 
band corresponding to 16S amplicon was excised from the gel and purified using 
Qiaquick gel extraction kit (Qiagen). After gel extraction the amplicon quantity and 
intergrity were both checked on agarose gel electrophoresis and Qubit BR DNA assay 
kit. Amplicon was stored at -20°C until use. 
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16S rDNA sequencing and statistics 
Sequencing of the amplicon pool was performed at Institut Curie NGS platform 
on an Ion Torrent PGM machine using the 318 chips. Raw sequencing output was 
demultiplexed and trimmed using in-house analysis pipeline (BCmm = 0, Pmm = 2, 
W = 50 bp, Q = 20, MinL = 200 bp and MaxL = 335 bp). Reads were clustered at 
97% of identity using vsearch pipeline (http://zenodo.org/record/15524#. 
VPIujy4f2J8). Chimeric OTU were identified using UCHIME (3) and discarded from 
downstream analysis. Taxonomy of representative OTU sequences was determined 
using RDP classifier (4). OTU sequences were aligned using ssu-align (5). The 
phylogenetic tree was inferred from the OTUs multiple alignments using Fattree2 (6).  
Statistical analyzes were performed using R program (7) and different related 
packages (Ade4 (8), Vegan (9), ape, phyloseq). Weighted unifrac distances (10, 11) 
were computed using microbiota abundance table and phylogenetic tree. Statistical 
tests were performed using the Wilcoxon test (p-value). Multiple tests were corrected 
using the False Discovery Rate method (q-value). 
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Discussion 
Although MAIT cells have been implicated in a number of infectious and 
autoimmune diseases (Table 2), their exact roles remain elusive, in part due to their 
scarcity in mice which hampers in vivo studies and therefore the understanding of 
MAIT cell biology. In this study, we describe a congenic mouse model with naturally 
increased frequency of MAIT cells. Together with reporter RORγt-GFP, we were able 
to study the characteristics of natural mouse MAIT cells.  
Like human MAIT cells, resting mouse MAIT cells are effector memory cells 
(CD44+CD62L−) and express the transcription factors RORγt and PLZF. In contrast, 
Tg MAIT cells were reported having a CD44lo PLZFlo naïve phenotype49. This 
implicates that the locus responsible for increased MAIT iTCR rearrangement may 
also have an impact on MAIT development. Thus, we studied the phenotype of MAIT 
cells from B6 and Vα19-Tg mice and found that B6 MAIT cells were memory 
(CD44hi) while Tg MAIT were mostly CD44lo with a small subset expressed PLZF, in 
agreement with recent results obtained using MR1-5-OP-RU tetramer65. The 
phenotypic differences of MAIT cells between WT and Tg mice may be due to the 
disrupted thymic development of T cells in Tg mice resulting from the prematuration 
and overexpression of the iTCRα115. Thus, MAIT cells from both CAST and B6 mice 
have a memory phenotype and the introduced CAST locus drives increases of MAIT 
cells.  
Regardless, the frequency of MAIT cells within T cell population in mouse is far 
lower compared to those in human. In contrast, the other invariant αβT cells 
population, iNKT cells are more abundant in mice. Both MAIT cells and iNKT cells 
are selected by DP thymocytes and they share functional similarities (Table 1). Thus, 
their competition during intra-thymic development or for peripheral niches may lead 
to the low frequency of MAIT cells in mice. However, we did not observe significant 
increases of NKT or MAIT cells from MR1−/− or CD1d−/− mice respectively.  
Microbiota plays an essential role in shaping immune system and regulating 
immune homeostasis116. Obviously, inbred mice raised in specific pathogen-free (SPF) 
conditions are exposed to a relatively restricted set of microbes whereas human 
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immune systems repetitively encounter a large variety of microbes. The importance of 
microbiota for MAIT development has been implicated in a number of studies11,18,20. 
Thus, the paucity of MAIT cells in mice may be due to the lack of specific human 
microbiota species. However, we performed the human microbiota reconstitution into 
TAP−/−Ii−/− germ free mice and did not observe increases of MAIT cells than those of 
SPF mice. In addition, in contrast to their oligoclonality in human, MAIT cells in 
mice express a polyclonal repertoire suggesting a lack of expansion of these cells. Of 
note, MAIT cells readily expand in response to pulmonary bacteria infection in B6 
mice and proliferate following bacterial stimulation in human54,59,81. It is possible that 
the rarity of MAIT cells in mice from SPF condition is due to the lack of microbial 
stimulation in the clean environment. In addition to MAIT cells, other memory T cell 
subsets (i.e., conventional CD4, CD8 T cells and NKT cells) also show diverse 
repertoires compared with those of human. The differences of lifespan and body size 
between human and mice may explain such common disparity.  
Given that human MAIT cells express the transcription factor RORγt, we therefore 
hypothesized that mouse MAIT cells also express this marker. By comparing MR1+ to 
MR1− mice, we observed a selectively larger RORγt-GFP+ population in the DN 
compartment and confirmed that iTCR Vα19-Jα33 chains were enriched in this 
population. Consistent with the expression of RORγt, mouse MAIT cells produce 
high levels of IL-17 following TCR or mitogen stimulation. Intracellular IFN-γ was 
solely observed in response to E.coli stimulation suggesting that a second signal, such 
as innate cytokine, is necessary for efficient IFN-γ production. Identification of mouse 
MAIT cells using MR1 tetramer revealed two MAIT populations: RORγt+ T-betlo IL-
17 producing subset and a minor RORγtlo T-bet+ IFN-γ producing subset65. As RORγt 
was used as a surrogate marker in our study, we mainly characterized RORγt+ DN 
subset. However, the release of IFN-γ we observed was from the RORγthi cells, which 
is reminiscent of the finding in human. In human, Turtle et. al showed that IL-12-
stimulated CD8α+ CD161hi CD62Llo cells, including MAIT cells, expressed higher T-
bet and IFN-γ, lost IL-17 secretion but preserved their RORγt expression62. This 
suggests that MAIT cells may retain functional plasticity and they can change their 
effector phenotype to cope with diverse immunological challenges.   
In addition to iTCR Vα7.2, CD161 has been generally used as a surrogate maker to 
identify human MAIT cells. CD161 is encoded by NKRP1A and its ligand is lectin-
like transcript 1 (LLT1). The mouse ortholog of CD161 is a family of genes Nkrp1a-g. 
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Although NK1.1 (NKR-P1C) has been used as a mouse CD161 in B6 mice, NKRP-
1B and D may represent a closer relation to CD161 as they bind to C-type lectin-
related ligand, Clr-b, which is the mouse ortholog of LLT157. Nevertheless, NK1.1 
was reported to be expressed on a large proportion of Vα19 Tg MAIT cells77. We 
therefore examined its expression on natural mouse MAIT cells and found that a 
subset of hepatic but not splenic MAIT cells expressed NK1.1. In contrast, by using 
MR1-5-OP-RU tetramer, Rahimpour et al. showed that NK1.1 was expressed by 
MAIT cells in thymus and spleen, but not in lung, which was in agreement with the 
CD4 expression by MAIT cells from these organs65. This is reminiscent of the 
phenotypes of different NKT functional subsets, in which NKT1 (T-bet+) cells 
express NK1.1 and are mostly CD4+, whereas NKT17 (RORγt+) cells lack both 
receptors (Figure 1)27. Due to the limitation of our study, we mainly characterized 
RORγt+ DN MAIT cells, which are NK1.1− in spleen. Thus, one can speculate that the 
expression of NK1.1 by MR1 tetramer+ cells in spleen may derive from CD4+ MAIT 
cells. Together with the expression of NK1.1, we also observed CXCR6 expression 
by hepatic MAIT cells. Critical roles of CXCR6 in homeostasis and activation of 
NKT cells have been documented117. Interestingly, in the liver of CXCR6−/− mice, 
NK1.1+ NKT cells were specifically reduced suggesting this liver-homing chemokine 
receptor may be important for NKT cell maturation117. Whether CXCR6 regulates 
NK1.1 expression on hepatic MAIT in a similar manner remains to be determined. 
Similarly, PLZF was also reported to promote the local residence of hepatic NKT 
cells by inducing the expression of adhesion molecule lymphocyte function-
associated antigen-1 (LFA-1). Whether PLZF plays a role on homing and adhesion 
properties of MAIT cells warrants further investigation.  
Like other innate-like T cells, MAIT cells have been shown to respond to innate 
cytokines, such as IL-12 and IL-1819,80,81,84. Given that mouse MAIT cells express 
high level of IL-12R and IL-18R, these findings may also hold true for mouse MAIT 
cells. We showed that mouse MAIT cells specifically respond to bacterial-derived 
antigens (i.e., semi-purified E.coli supernatant or 5-OP-RU) in an MR1-dependent 
manner. However, when stimulated with whole E.coli, MAIT cells exhibited higher 
expression of activation makers (CD25+CD69+) and this activation cannot be blocked 
using anti-MR1 antibody (not depicted). Moreover, in transwell culture with either 
WT or MR1− bone marrow-derived dendritic cells infected with E.coli, MAIT cells 
were able to upregulate activation markers CD69 and CD25, suggesting these cells 
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responded to soluble factors, possibly IL-12, because their activation was 
compromised by IL-12 blocking antibody (not depicted). In contrast, blocking MR1 
had no effect on such stimulation. Their response to cytokine-mediated stimulation 
may be important to ensure immediate MAIT activation in response to any infectious 
stimuli that induce the production of innate cytokine, irrespective of the expression of 
microbial antigens, thus allowing MAIT cells to overcome their restricted TCR 
specificity. Accordingly, in line with previous findings, our data suggest that innate 
cytokine rather than MR1-TCR dominates MAIT cells activation and possibly 
effector function in control of bacterial infection.  
Collectively, our results show that natural mouse MAIT cells preferentially reside 
in peripheral non-lymphoid tissues. They exhibit an effector-memory phenotype and 
coexpress transcription factors PLZF and RORγt. They have high expression of 
cytokine receptors, respond to both TCR and innate cytokine stimulation, and are able 
to produce IFN-γ and IL-17. Altogether, our results demonstrate that mouse MAIT 
cells resemble human MAIT cells more closely than previously thought. Accordingly, 
the generation of a relevant mouse model allows further understanding of MAIT cell 
biology in health and disease.  
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Perspectives 
MAIT cells are now emerging as an important cell population at mucosal surface, 
potentially bridging innate and adaptive immunity. However, much of the current 
knowledge on MAIT cells stems from in vitro analyses and still requires experimental 
models for a better understanding of this innate lymphocyte population.  
The mouse model described in this thesis is a promising tool for advancing our 
knowledge on MAIT cells. Although we succeeded in identifying mouse MAIT cells 
and studying their features using surrogate marker RORγ-GFP, several other 
challenges lie ahead. One such issue concerns how reliable the surrogate marker 
RORγ-GFP is. Downregulation of Rorc (RORγt) and reciprocal upregulation of TH1 
factor Tbx21 (T-bet) has been reported in committed TH17 cells stimulated by IL-
12118. This correlated with corresponding downregulation of Il17a, and upregulation 
of Ifng118. Although others and we observed IFN-γ producing MAIT cells preserved 
RORγt expression62, we cannot rule out that MAIT cells may downregulate RORγt 
under certain conditions. For such reason, RORγ-GFP may not be ideal to label 
activated MAIT cells. Thus, MR1 tetramers are indeed required for a more reliable 
identification of MAIT cells in the future work.  
Although we have a growing understanding of MAIT cells, a number of important 
questions are still unsolved. By providing a physiologically relevant mouse model, we 
hope to facilitate MAIT research.  
The development of MAIT cells has been poorly investigated. Microbiota has been 
implicated in MAIT cells development11,18,20. However, the finding of mature MAIT 
cells from fetus suggests that MAIT cells may undergo developmental maturation 
prior to the colonization of commensal microbes54. What definitive role microbiota 
plays during MAIT development is still an open question. Like NKT cells, MAIT 
cells are selected by DP thymocytes and require PLZF during development64,65. The 
endogenous ligand for thymic MAIT selection and to what extent NKT and MAIT 
cells share developmental program are not known.  
MAIT cells have been suggested having the potential to enhance immune 
responses, whether they play an immunoregulatory role remains to be addressed.  
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Several studies suggested that MAIT cells might selectively expand and 
discriminate specific microbial antigens in the context of bacterial infections76,85. On 
the other hand, they respond to innate cytokine stimulation, regardless of the presence 
of microbial ligands19,62,80,81,84. Understanding how MAIT cells are regulated and 
what features selective antigens have will open up the potential for the designing of 
MAIT-targeted adjuvant and vaccine.  
Given that MAIT cells react to BCG-infected cells in vitro and are able to recruit to 
the infected bladder during urinary tract infection, they may possibly participate in 
immune responses to intravesical BCG instillation for treating bladder cancer. 
Understanding whether MAIT cells contribute to BCG immunotherapy will provide a 
unique opportunity for novel therapeutic intervention.  
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Double Positive Thymocytes Select Mucosal-Associated
Invariant T Cells
Natalie Seach,*,1,2 Lucia Guerri,*,2,3 Lionel Le Bourhis,* Yvonne Mburu,*
Yue Cui,* Ste´phanie Bessoles,* Claire Soudais,* and Olivier Lantz*,†
NKT and mucosal-associated invariant T (MAIT) cells express semi-invariant TCR and restriction by nonclassical MHC class Ib
molecules. Despite common features, the respective development of NKTandMAIT subsets is distinct. NKTs proliferate extensively
and acquire effector properties prior to thymic export. MAIT cells exit the thymus as naive cells and acquire an effector/memory
phenotype in a process requiring both commensal flora and B cells. During thymic development, NKTs are selected by CD1d-
expressing cortical thymocytes; however, the hematopoietic cell type responsible for MAIT cell selection remains unresolved. Using
reaggregated thymic organ culture and bone marrow chimeras, we demonstrate that positive selection of mouse iVa19 transgenic
and Vb6 transgenic MAIT cell progenitors requires MHC-related 1–expressing CD4+CD8+ double positive thymocytes, whereas
thymic B cells, macrophages, and dendritic cell subsets are dispensable. Preincubation of double positive thymocytes with
exogenous bacterial ligand increases MHC-related 1 surface expression and enhances mature MAIT cell activation in the
in vitro cocultures. The revelation of a common cell type for the selection of both NKT and MAIT subsets raises questions about
the mechanisms underlying acquisition of their specific features. The Journal of Immunology, 2013, 191: 6002–6009.
L
ymphocytes restricted by nonclassicalMHC class Ib (MHC-
Ib) molecules exhibit unique features of both innate and
adaptive immunity (1). Only two subpopulations of innate-
like T lymphocytes display conservation between species of both
TCR and their respective MHC-Ib–restricting element: the CD1d-
restricted NKT and the more recently defined MHC-related 1
(MR1)–restricted mucosal-associated invariant T cell (MAIT) (2, 3).
MAIT cells are defined by expression of a semi-invariant TCR
consisting of a canonical iVa7.2-Ja33 iTCRa-chain in humans
(iVa19-Ja33 in mice) associated with a limited set of Vb segments
(Vb2, 13, 22 in humans and Vb6, 8 in mice) (4). Indicative of
strong selective pressure, both the MAIT iTCR and its restriction
partner, MR1, are highly conserved between species (4, 5)
MAIT are double negative (DN) and CD8abint or CD8aa in
humans and are abundant in the human blood (1–8% of T cells)
and liver (20–50%) but are rare (0.03–0.1%) in conventional mouse
strains (4, 6, 7). In contrast, NKTs are abundant in laboratory
mice but constitute less than 1% of human blood T cells (3). NKT
cells recognize glycolipids presented by CD1d (8), whereas human
MAIT cells were recently shown to react against metabolites of the
riboflavin (vitamin B2) biosynthetic pathway (9). These riboflavin
metabolites represent a novel class of Ag, whose distribution among
microorganisms is consistent with the broad anti-microbial reac-
tivity of MAIT cells to bacteria and yeast, but not virus (10, 11).
MAIT cells may regulate intestinal microbiota or protect against
specific bacterial infection (12).
Both NKT and MAIT cells require a functional thymus for
selection (4, 13). However, although similarities exist, their de-
velopmental pathways are distinct. NKT cells are selected, and
expand and acquire their effector/memory phenotype in the thy-
mus, whereas MAIT cells exhibit minimal intrathymic prolifera-
tion and display a naive phenotype in both human thymus and
cord blood (6, 7, 14).
Human MAIT cells express high levels of the C-type lectin
CD161 as well as the IL-18R in cord blood, indicative that their
specific differentiation program is already set in the thymus (6,
7, 15). Following thymic egress, MAIT cells undergo extensive
clonal expansion and acquire their effector/memory phenotype in
a process dependent upon both B cells and the commensal flora (2,
7, 15). In addition to IFN-g, human MAIT cells secrete IL-17,
consistent with their uniform expression of the retinoic acid–re-
lated orphan receptor gt isoform (6). Interestingly, both human
NKT and MAIT cells express the transcription factor ZBTB16
early in ontogeny, indicating at least a partial overlap in their initial
developmental programming (15, 16).
The nature of the thymic selecting cell plays an important role
in determining conventional T, NKT, or MAIT cell differentiation
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programs. Indeed, conventional abT cell development stems from
interactions with classical MHC/peptide complexes presented by
thymic epithelium, whereas the expression of MHC-Ib molecules
by hematopoietic elements likely leads to the intrinsic effector
function of “innate-like” T cell subsets (1, 17, 18). Indeed, he-
matopoietic cells (HCs) select the majority of T cells restricted
by MHC-Ib molecules: H2-M3–restricted (19), NKT (13), and
MAIT cells (2). NKTs are selected exclusively by CD4+CD8+
double positive (DP) thymocytes (20). H2-M3–restricted T cells
can be selected upon both epithelium and HCs; however, the latter
imparts enhanced effector functions dependent upon signaling
lymphocyte activation molecule (SLAM)–associated protein (SAP)
transduction (18).
The identity of the HC type responsible for MAIT cell selection
remains unresolved (2, 20). Initial bone marrow (BM) chimera
studies found normal levels of Va19-Ja33 transcript in the mes-
enteric lymph nodes (MLNs) of mice when MHC-I expression
was confined to CD3ε2/2 donor BM. These findings suggested
that MR1 expression by T cells, in contrast to NKT cells, was not
required for intrathymic MAIT cell selection and that other thymic
HCs were likely involved. Aside from the abundant epithelial and
mesenchymal components, the thymic stroma consists of rare HC
types, including dendritic cells (DCs), macrophages (Macs), and
B cells (21). Subsequent studies have demonstrated that MAIT
cells develop normally in fetal thymic organ cultures in the ab-
sence of B cells and exogenous microbial ligand, indicating a non-
requirement for these components (7).
The virtual absence of detectable MR1 surface expression on
primary cells has hampered efforts to identify the cell type(s) in-
volved in the intrathymic selection of MAIT cells. Recently, in-
creased intracellular expression of MR1 has been reported for
DP thymocytes, which, alongside Macs and DC, could stimulate
MAIT cell hybridomas in the presence of a stabilizingMR1Ab (22).
Despite these potential candidates, the cell type(s) responsible for
MAIT cell selection remains elusive. This issue is important, as the
array of secreted and surface molecules available for cell–cell in-
teraction differs across the cell lineages and likely imparts unique
signals in the specification of T cell phenotype and function. To
identify the HC type(s) implicated in MAIT cell development, we
used reaggregated thymic organ culture (RTOC) and bone marrow
transplantation (BMT) assays to assess the requirement of specific
thymic components in the selection process.
Materials and Methods
Mice
C57BL/6 mice were obtained from Charles River Laboratories animal
facility, Labresles France. TAP2/2 Ii2/2 Vb6 transgenic (Tg) MR1+/2 (and
MR12/2), iVa19 Tg Ca2/2 MR1+/2 (and MR12/2), RAG22/2MR1+/2
(and MR12/2), and CD3ε2/2 mice have been previously described else-
where (7) and were maintained under specific pathogen–free conditions at
the central animal facility, Institut Curie, Paris, France. BM from TCRa2/2
mice was kindly provided by A. Lehuen (INSERM U986, Paris). All animal
experiments were performed in accordance with the guidelines of the
French Veterinary Department in an accredited mouse facility.
Time matings
Overnight matings for 2 consecutive days were set up between TAP2/2Ii2/2
Vb6 Tg MR12/2 mating pairs. Pregnant females were sacrificed between
days E14and E16 to harvest embryos. Approximately 6–10 pregnant mice
were used per RTOC experiment.
Anti-CD3 Ab treatment of RAG2/2 mice
Adult RAG2/2MR1+/2 (and MR12/2) mice were injected i.p. with 200 mg
anti-mouse CD3 (145-2C11) (eBioscience) to induce DP thymocytes (23).
Mice were sacrified at day 8 post injection, and the thymus was analyzed
for development of DP thymocytes and subsequent use in the RTOC assay.
RTOC
E14-E16 TAP2/2Ii2/2 Vb6 Tg MR12/2 thymic lobes were isolated as
previously described (24). Pooled lobes were digested in 1 ml RPMI 1640
containing 0.5 (Wu¨nsch) units/ml Liberase (Roche) and 0.02% (w/v)
DNase I at 37˚C for 30 min. Embryonic digest was incubated with anti-
CD45 microbeads and separated using the AutoMACS Separator (Miltenyi
Biotec) to enrich for stromal cells, which were resuspended in RTOC
media: DMEM GlutaMAX 10% FCS, 100 U/ml penicillin, 100 mg/ml
streptomycin, 50 mM 2-ME, 10 mM HEPES, 1 mM nonessential amino
acids, and 1 mM sodium pyruvate (all from Life Technologies).
The iVa19 Tg thymocyte progenitors were prepared from pools of day
3–5 neonatal thymus from CD45.2+ iVa19 Tg Ca2/2MR12/2 mice. Vb6
Tg fetal thymocytes were obtained from CD45.2+ TAP2/2Ii2/2 Vb6 Tg
MR12/2 E14–E16 embryos. A total of 5 3 105 iVa19 or Vb6 Tg thy-
mocytes were mixed with 4 3 105 supporting thymic stromal cells (TSCs)
from TAP2/2 Ii2/2MR12/2 embryos. RTOCs were complemented with
2.5 3 105 purified CD45.1+ thymocytes or candidate CD45.1+ hemato-
poietic TSC (hTSC) subsets (Supplemental Fig. 1). Total cell mixture was
delivered with a 10-ml pipette tip as a standing drop onto a Millipore filter
(0.8-mm pore size, 13-mm diameter) resting on the surface of 2.5 ml
RTOC media in 60-mm petri dishes and incubated at 37˚C with 5% CO2. A
culture period of 6 and 9 d, respectively, was required for optimal matu-
ration of iVa19 Tg and Vb6 Tg thymocytes in the RTOC system (data not
shown). Following incubation, RTOCs were digested with Col/DNAse
to release thymocytes and were stained with surface Abs to assess Tg
MAIT cell development.
Immunostaining and flow cytometric analysis
All cell samples were incubated with anti-FcR supernatant (clone 2.4G2)
prior to Ab staining. The following anti-mouse fluorochrome or biotin-
conjugated Abs were purchased from eBioscience, BD Pharmingen, and
BioLegend unless otherwise stated: CD11b (clone M1/70), CD11c (N418),
CD19 (1D3), CD25 (PC61.5) CD4 (LT34), CD44 (IM-7) CD45.2 (104),
CD8a (Ly-2), CD90.1 (HIS51), CD90.2 (30-H12), EpCAM (G8.8), F4/80
(BM8), HSA (M1/69), TCRb (H57-597), Vb6 (RR4-7), Vb8 (F23.1),
CD69 (clone [1H].2F3), CD44 (IM7). Cells were acquired with an LSR2
cytometer (Becton-Dickinson), using DAPI to exclude dead cells, and were
analyzed using FlowJo software v9.4.11 (TreeStar).
Cell preparation and separation of adult thymus subsets
The hTSC subsets (DCs, B cells, and Macs) and thymocyte subsets were
purified from adult CD45.1+ B6 (MR1wt/wt) mice. For hTSC subsets, pools
of four to five thymuses were enzymatically digested, as previously de-
scribed (21). To enrich for hTSC subsets, cells were incubated with anti-
CD5 microbeads to deplete thymocytes and run through an AutoMACS
Separator. Enriched hTSC subsets were immunolabeled and separated
according to defined antigenic surface expression [(25), Supplemental Fig.
1] using a FACSAria III cell sorter (BD Biosciences). Whole thymocytes
were purified based on positive expression of CD90. DN, DP, and single
positive (SP) thymocyte subsets were purified using anti-CD4 and anti-CD8
Abs. DN cells were further gated negative for lineage expression (CD19,
F4/80, CD11c, CD11b) to avoid contamination with non–T cells. Thymic
epithelium was purified from digested tissue on the basis of negative CD45
and positive EpCAM expression (21). Thymic subsets were collected in
50% FBS in RPMI 1640. Following the sort, subsets were resuspended in
RTOC media, enumerated, and stored on ice until further use.
BM transplantation
Groups of four to five adult RAG2/2MR12/2 hosts were irradiated (900
cGy) and reconstituted with 10 3 106 donor BM cells prepared from
CD45.2+ Va19 Tg MR12/2 mice either alone or in combination with BM
from B6 CD45.1+, RAG2/2, TCRa2/2, or CD3ε2/2 mice [all MR1wt/wt
(wt, wild type)]. The thymus and MLNs from transplanted mice were
harvested at 8 wk post BMT and assessed for iVa19 Tg T cell development.
Bacterial ligand preparation and stimulation assay
The preparation of the bacterial supernatant will be described elsewhere
(C. Soudais and O. Lantz, manuscript in preparation). Briefly, Escherichia
coli were grown to saturation. Supernatant was collected, filtered, bio-
chemically processed before being aliquoted, and lyophilized for further
use. One arbitrary unit corresponds to 25 ml bacterial supernatant. Whole
splenocytes from iVa19 Tg Ca2/2 MR1+/2 or BM chimeric mice were
depleted of APCs and CD4+ T cells. A total of 2.5 3 105 purified DN, DP,
and SP thymocyte subsets from MR1+/+ and MR12/2 mice or 2.5 3 105
purified splenic APCs from MR1+/+ mice were preincubated with serial
dilutions of semipurified bacterial ligand for 30 min before adding 2.5 3
The Journal of Immunology 6003
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105 iVa19 Tg responder cells. After an 18-h coculture, cell activation was
monitored by cytometry analysis.
MR1 surface staining
Purified DP thymocytes from MR1+/+ and MR12/2 mice were incubated for
4 h in RTOC medium 6 4 arbitrary units of purified bacterial ligand (E. coli).
Following incubation, MR1+ and MR12 cells were stained with anti-MR1
Ab (clone 26.5) (26). Primary Abs were detected with F(ab9)2 fragment goat
anti-mouse IgG–PE conjugate (Jackson ImmunoResearch Laboratories).
Quantitative PCR for MR1 expression
RNA isolation was performed on purified adult thymocyte (DN, DP, and SP)
subsets and total thymic epithelium, using the RNAqueous-Micro Kit. After
reverse transcription, quantitation ofMR1 andGAPDH cDNAwas performed
using Assays-on-Demand primers provided by Applied Biosystems. MR1
expression was normalized to GAPDH content, using the DDct method.
Statistical analysis
Statistical analysis was performed using the nonparametric Mann–Whitney
U test. In Figs. 1E, 1F, 2D, and 2E, fold expansion refers to the number of
mature Vb6 T cells in each RTOC of the experimental groups, compared
with the average of the ones measured in the control group.
Results
Thymocytes mediate selection of MAIT cells in RTOC
To determine the cell type responsible for intrathymic MAIT cell
selection, we employed RTOC techniques, which enable the in
vitro differentiation of T cell progenitors in the presence of de-
fined stromal and hematopoietic elements (27). As MAIT cells are
rare in laboratory mice, reliable detection in the thymus is diffi-
cult. We took advantage of two well-characterized Tg mouse
models expressing an invariant Va19-Ja33 TCRa-chain (iVa19
Tg) or Vb6 Tg TCRb-chain from a MAIT hybridoma (4, 7). Vb6
and Vb8 segments are overexpressed in iVa19 Tg Ca2/2 mice
(hereafter iVa19 Tg) in an MR1-dependent manner, whereas an
MR1-dependent increase in iVa19-Ja33 chain use is found in
Vb6 Tg mice and reflects MAIT cell selection (7). RTOC relies on
embryonic TSCs, which reorganize to form a three-dimensional
microenvironment capable of supporting T cell development and
maturation in vitro (27). To further increase MAIT cell frequency,
we used stroma from TAP2/2Ii2/2 mice, as the absence of clas-
sical MHC molecules decreases mainstream T cell selection (7).
To assess selection of iVa19 Tg T cell progenitors, whole
thymocytes were isolated from neonatal CD45.2+ iVa19 Tg Ca2/2
MR12/2 mice and mixed with supporting TSCs from TAP2/2Ii2/2
MR12/2 embryos. Candidate CD45.1+MR1+-selecting cells were
isolated from adult thymus tissue, as outlined in Supplemental Fig.
1. Purified CD45.1+ Thy1+ adult thymocytes were added to RTOC
at a ratio of 1:1 with iVa19 Tg progenitors. The hTSC subsets, in-
cluding DCs, Macs, and B cells, were seeded into RTOCs according
to their original representation within adult thymus, and adjusted
for cell death and potential loss during preparation (Supplemental
Fig. 1). As a positive control, whole CD45.1+ MR1+ thymus sus-
pension was added to RTOC in which all potential thymus-selecting
cell types are present.
Following incubation, RTOCs were analyzed by flow cytometry
for Tg T cell development, as described in Fig. 1A: Significant
maturation of iVa19 Tg T cells was consistently observed, as in-
dicated by the development of a prominent TCRbhighHSAlow subset
(panel Aiii). Mature Tg thymocytes were mostly DN or CD8+
(panel Aiv) with little CD4+ T cell development as observed in
iVa19 Tg mice (7). The proportion of Vb8+ cells (Fig. 1B) in both
mature DN and CD8 subsets was determined for control (panel Bi)
and test RTOCs (panel Bii) as a readout for MAIT cell selection.
The baseline use of Vb8 segments by iVa19 Tg thymocytes was
∼ 23% for both DN (Fig. 1C) and CD8 (Fig. 1D) subsets in control
RTOCs, which did not contain any MR1-sufficient cells. In con-
trast, addition of MR1+ whole adult thymus suspension increased
the Vb8 proportion within both mature DN and CD8 Tg subsets,
indicating the presence of a selecting cell type within adult thymic
tissue. In line with previous data, the addition of MR1+ B cells did
not affect MAIT cell development (7). However, purified MR1+
thymocytes readily induced Vb8 bias, at a level similar to that
seen with whole thymus cells. In contrast, purified MR1+ DCs and
Macs did not induce a Vb8 bias in either DN (Fig. 1C) or CD8
(Fig. 1D) iVa19 Tg thymocyte subsets.
To verify that iVa19 Tg MAIT progenitors had undergone proper
thymic selection, as opposed to aberrant activation/expansion of
mature thymocyte subsets, iVa19 Tg RTOCs were complemented
with CD45.1+ MR1+ adult thymocytes, as previously described
and analyzed for phenotypic markers of thymocyte development.
In line with positive selection (28), upregulation of the early ac-
tivation marker CD69 was observed on a fraction of TCRbhi CD4+
CD8+ DP thymocytes and mature Vb8+ iVa19 Tg thymocytes
following 6 d of RTOC culture (Supplemental Fig. 2A). Anal-
ysis of the activation/memory markers CD25/CD44 on mature
DN/CD8+ iVa19 Tg thymocytes revealed that a small propor-
tion of Vb8+ thymocytes expressed CD44 but did not express
CD25 (Supplemental. Fig. 2C, 2D). Importantly, the proportion
of Vb8+CD44+ or Vb8+CD25+ iVa19 Tg thymocytes did not
increase following complementation with MR1+ thymocytes,
arguing against confounding activation/expansion (Supplemental
Fig. 2D). Taken together, our data demonstrate that MR1+ thy-
mocytes, but not other HC cell types, can mediate the efficient
selection and maturation of iVa19 Tg MAIT cells in our in vitro
RTOC system.
Forced expression of Tg TCRa-chains can modify T cell on-
togeny (29) We therefore assessed the selection of Vb6 Tg MAIT
cell progenitors in the RTOC system. Whole Vb6 Tg thymocytes
from E15 Vb6 Tg TAP2/2Ii2/2MR12/2 fetal thymus were reag-
gregated with supporting stroma plus or minus candidate CD45.1+
MR1+–selecting cells. MAIT cell development was assessed as
in Fig. 1A. In the absence of MR1, we observed little maturation
of Vb6 Tg fetal thymocyte progenitors, as demonstrated by the
small number of Vb6+ events in mature Tg thymocyte subsets
from control RTOCs (Fig. 1Biii). However, a clear expansion of
mature Vb6+ thymocytes was observed in both DN and CD8
subsets (Fig. 1Biv), upon the addition of whole MR1+ thymus as
well as purified MR1+ thymocytes (Fig. 1E, 1F). In line with the
development of iVa19 Tg thymocytes, Vb6 Tg thymocytes up-
regulated CD69 and retained a predominantly naive phenotype
upon maturation in RTOC, indicative of proper thymic selection
(Supplemental Fig. 2). Notably, MR1+ thymic B cells, DCs, or
Macs did not induce Vb6+ Tg thymocyte development above that
of control levels, indicating a specific role for MR1+ thymocytes
in MAIT cell selection (Fig. 1E, 1F).
DP thymocytes govern MAIT cell development
abT cell development occurs in an ordered fashion. CD32CD42
CD82 triple negative (TN) immature thymocytes develop into
CD4+CD8+ (DP) before positive selection and maturation into
CD4+ or CD8+ SP subsets. Whole MR1+ thymocytes were shown
to mediate selection of both iVa19 and Vb6 Tg progenitors. To
assess the capacity of discrete thymocyte subsets to select MAIT
cells, we used RAG-deficient mice in which thymocyte develop-
ment is arrested at the early TN3 stage. Injection of anti-CD3 Abs
into these mice induces differentiation into DP, but not SP, thy-
mocyte subsets [Fig. 2A, (23)]. Cells from the RAG2/2 thymus
were incapable of mediating MAIT cell selection, as shown by the
absence of Vb8 bias (Fig 2B, 2C) or Vb6 T cell expansion (Fig.
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2D, 2E) in DN and CD8+ subsets from respective iVa19 and Vb6
Tg RTOCs. Importantly, in addition to early thymocyte subsets,
the RAG2/2 thymus contains significant numbers of DCs and
Macs, further supporting the idea that these hTSC subsets do not
participate in early MAIT cell selection events. In contrast, the
addition of thymocytes from RAG2/2 MR1+/2 mice, in which
DPs had been induced via anti-CD3 stimulation, robustly induced
MAIT cell selection in both iVa19 Tg (Fig. 2B, 2C) and Vb6 Tg
(Fig. 2D, 2E) RTOC systems. Importantly, the ability of DP to
select MAIT cells was strictly dependent upon the presence of
MR1, as thymocytes from anti-CD3–treated RAG2/2 MR12/2
mice were incapable of inducing MAIT cell selection (Fig. 2).
Notably, the capacity of DP thymocytes to select MAIT cells
appeared to be strictly temporally regulated, as the addition of
purified mature MR1+ SP thymocytes did not allow for MAIT cell
selection (Fig. 2B–E).
The singular ability of DP thymocytes to select MAIT cells is
reminiscent of NKT cell development (13, 20). However, in
contrast to CD1d, MR1 is undetectable on the surface of DP
thymocytes (13, 22). Of interest, MR1 mRNA levels were 25 fold
higher in DP thymocytes than in DN, SP, or thymic epithelium
(Supplemental Fig. 3). This finding is consistent with previous
reports that demonstrated increased intracellular expression of
MR1 protein in the DP subset and indicates that DP thymocytes
are primed for MAIT cell selection (22). Thus, similar to NKT
cells, DP thymocytes appear to play a unique and nonredundant
role in the selection of MAIT cells, whereas other hematopoietic
elements are dispensable.
FIGURE 1. Thymocytes mediate
MAIT cell selection in RTOC. iVa19
or Vb6 Tg MR12 thymocytes were re-
aggregated with TAP2Ii2MR12 thymic
stroma without (control RTOC) or with
the indicated MR1+ cells and analyzed
6 and 9 d later for iVa19 or Vb6 inocula,
respectively. (A) Gating strategy: (Ai)
Lymphocytes gated on forward/side scat-
ters, (Aii) Live CD45.2+ iVa19 Tg thy-
mocytes, (Aiii) TCRbhiHSAlo mature
thymocytes, and (Aiv) Mature, DN and
CD8 subsets. (B) Representative dot plots
of DN and CD8 subsets from iVa19
(Bi, Bii) and Vb6 Tg thymocytes (Biii,
Biv). Vb8 use (C, D) and Vb6 fold ex-
pansion (E, F) in RTOCs without (2) or
with complementation by the indicated
MR1+ subset (see Materials and Methods
for the computation). FACS plots are
representative, n = 8–10. Each dot rep-
resents an individual RTOC pooled from
. 10 individual experiments. *p , 0.05
compared with control RTOCs.
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DP thymocytes regulate in vivo MAIT cell development
To assess the development of MAIT cells in vivo, we generated
BM chimeras in which MR1 expression was restricted to defined
thymic cell types. Adult RAG2/2MR12/2 hosts were irradiated
and reconstituted with donor BM from CD45.2+ iVa19 Tg MR12/2
mice, as a source of MAIT cell progenitors, either alone or com-
plemented with BM from MR1+ CD45.1+ wt or T/B cell-deficient
mice. In this setting, iVa19 Tg MR12/2 thymic progenitors en-
counter MR1 expressed by all hematopoietic lineages when ad-
ministered with wt BM, whereas MR1 expression is restricted to
TN and DP thymocyte subsets when administered with CD32/2
and TCRa2/2 donor BM, respectively. Complementation with
RAG2/2 BM will lack expression of MR1 on both T and B cells
and confine expression to Mac and DC subsets.
Successful BM reconstitution was determined 8 wk post BMT by
the development of mature CD45.2+CD3+ (iVa19 Tg) T cells in the
thymus and MLNs, as assessed by flow cytometry. Mice reconstituted
with iVa19 Tg MR12/2 BM alone generated mature thymocytes
with a baseline expression of Vb8 segments (∼19%) for both DN
(Fig. 3A) and CD8 (Fig. 3B) subsets. Addition of wt CD45.1 BM to
iVa19 Tg MR12/2 BM rescued MAIT cell development, as dem-
onstrated by the significant increase of Vb8 segment use in mature
DN (∼40%) and CD8 (∼35%) subsets. Importantly, complementation
with TCRa2/2, but not RAG2/2, donor BM significantly increased
Vb8 bias within both mature DN and CD8 subsets (Fig. 3A, 3B), at
a level comparable to that of wt donor BMT (Fig. 3A).
In the MLN, addition of wt and TCRa2/2 BM, but not RAG2/2
BM, increased Vb8 use in CD3+ DN (Fig. 3C) and CD8+ (Fig. 3D)
iVa19 Tg T cell subsets. The Vb8 bias in the CD8 subset was less
apparent after complementation with wt BM (Fig. 3D) and may be
related to low-level peripheral expansion of CD8 T cells on clas-
sical MHC-I molecules, as a Vb8 bias is already observed in the
absence of MR1+ BM complementation. B cells are not required
for intrathymic MAIT cell selection [Fig. 1A, (7)] but are critical
for expansion of peripheral MAIT cells (2). Thus, it is possible that
some MAIT cell selection is occurring in the thymus of mixed
iVa19 Tg MR12/2/RAG2/2 chimeras but is undetectable in pe-
ripheral organs owing to a lack of MR1+ B cell–mediated expan-
sion. iVa19 Tg MR12/2 BM was therefore complemented with
CD3ε2/2 BM in which MR1+ B cells, but not T cells, are present.
Even in the presence of MR1+ B cells, no increase in Vb8 use was
observed in either the thymus (Fig. 3A, 3B) or the MLN (Fig. 3C,
3D) of mixed iVa19 Tg MR12/2/CD3ε2/2 chimeric mice.
To assess the functional capacity of MAIT cells selected in BM
chimeras, APC-depleted splenocytes from chimeric BMT mice
were cocultured with purified MR1+ splenic APCs preincubated
with exogenous bacterial ligand purified from E. coli. Following
overnight incubation, iVa19 Tg T cells (gated DN/CD8+ Vb8+)
were analyzed for expression of activation markers CD25/CD69
by flow cytometry (Fig. 3E). Notably, only T cells from iVa19 Tg/
TCRa2/2 chimeric mice, but not iVa19 Tg or iVa19 Tg/RAG2/2
chimeric mice, upregulated CD25/CD69 in cocultures indicative
of functional MAIT cell selection (Fig. 3F).
Together, these data indicate that selection of functional, MR1-
reactive iVa19 Tg MAIT cells requires MR1 expression exclu-
sively by DP thymocytes and that early thymocytes as well as
MR1-sufficient resident thymic DC and Mac populations cannot
induce functional MAIT cell development.
The finding that DP thymocytes are required exclusively for
MAIT selection is surprising, given our earlier studies showing
significant iVa19-Ja33 transcript in the MLNs of wt chimeric
mice, in which MHC I expression was confined to CD3ε2/2 BM
FIGURE 2. DP thymocytes regulate intra-
thymic MAIT cell development. RTOCs were
performed as in Fig. 1 and complemented with
whole thymus from the indicated RAG2/2 mice
or TCRbhi SPs from wt mice. (A) Injection of
anti-CD3 Ab generates DP thymocytes in RAG2/2
mice. Vb8 use (B, C) and Vb6 fold expansion
(D, E) in RTOCs without (2) or with comple-
mentation by the indicated cells. FACS plots
are representative (n = 5). Each dot represents
an individual RTOC pooled from two to three
separate experiments. *p , 0.05 compared with
cells from untreated RAG mice.
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(2). Although we cannot rule out the possibility of a very small
amount of intrathymic MAIT cell selection, in the absence of MR1+
T cells, followed by B cell–mediated peripheral expansion in our
former experiments, the current data from both RTOC and BM
chimeras in this article strongly suggest that the overwhelming
majority of MAIT cell selection occurs upon reciprocal interac-
tion between MR1-expressing DP thymocytes.
DP thymocytes can present exogenous ligand to MAIT cells
in vitro
At steady state, the surface expression of MR1 is undetectable on
primary cells (26). To determine the presence of functional MR1
molecules on DP thymocytes, we assessed the capacity of these
cells to be loaded with, and present, exogenous ligand to periph-
eral MAIT cells. Importantly, riboflavin and folate derivatives,
present in most culture media, are unable to activate human
MAIT cells (9) and mouse iVa19 Tg T cells (data not shown).
Purified wt thymoycte subsets were cocultured with mature iVa19
Tg Ca2/2 MR1+/2 MAIT cells in the presence or absence of
bacterial ligand. In accordance with a previous report (22), DP
thymocytes alone did not stimulate Tg MAIT cells, as indicated by
the absence of surface CD25/CD69 expression. However, when
preincubated with increasing concentrations of exogenous ligand,
DP thymocytes activated MAIT cells in a dose- and strictly MR1-
dependent manner (Fig. 4A, 4B). Notably, both immature DN and
mature SP subsets harbored limited stimulatory capacity, in line
with their inability to mediate intrathymic MAIT cell selection
within both in vitro and in vivo models.
The ability of DP thymoyctes to stimulate mature MAIT cells
following loading with bacterial ligand correlated with a slight,
but reproducible, upregulation in MR1 surface expression as as-
sessed by flow cytometry (Fig. 4C). Anti-MR1 staining (clone
26.5) was undetectable on untreated DP from MR1-sufficient mice
when compared with control staining on MR12/2 DP thymocytes.
Incubation with bacterial ligand, however, resulted in the rapid
upregulation of MR1 surface expression after a 4-h coculture (Fig.
4C). The lack of detectable surface MR1 expression on ex vivo DP
is reminiscent of H2-M3 molecules, which, in the absence of li-
gand, remain largely in the endoplasmic reticulum and suggests
that endogenous ligand availability may also limit MR1 surface
expression at steady state (26). It is likely that provision of the
bacterial ligand results in the increased trafficking of intracellular
MR1 to the surface and/or stabilized surface expression, thereby
enhancing the capacity of DP to activate MAIT cells in vitro.
These data strongly support a role for MR1/endogenous ligand
complexes in the positive selection of MAIT cell progenitors.
Discussion
In this study we resolve a longstanding question regarding the identity
of the thymic cell type responsible for MAIT cell selection. Using
FIGURE 3. DP thymocytes regulate MAIT cell development in vivo. iVa19 Tg MR12/2 BM was administered to RAG-/ MR12/2 recipient hosts either
alone (2) or in combination with BM derived from the indicated MR1+ wt or T/B cell–deficient mouse strain. Percentage Vb8 use was measured for Va19
Tg mature thymocyte subsets (A, B) and MLN (C, D). Each dot represents an individual mouse pooled from two separate experiments. (E and F) Purified
iVa19 Tg splenic cells isolated from the indicated BMT group were cocultured with MR1+ APCs plus bacterial ligand and assessed for surface expression
of CD25/CD69 by flow cytometry (E). (F) Graph shows percentage activation of iVa19 Tg T cells (gated DN/CD8+ Vb8+) following overnight incubation
with indicated ligand concentration. *p , 0.05 compared with control groups.
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discrete thymic hematopoietic subsets, we demonstrate a unique and
nonredundant role for DP thymocytes in the selection of MAIT cell
precursors, whereas all other thymic subsets were dispensable.
Surface MR1 protein is undetectable on primary cell lines, and it
is highly probable thatMR1 is not stable at the cell membrane in the
absence of endogenous or exogenous ligand (9, 26, 30). Indeed, we
show that exposure to cognate bacterial ligand resulted in the rapid
upregulation of MR1 membrane expression by DP thymocytes and
the activation of peripheral MAIT cells. Although the identity of
the endogenous MAIT ligand remains unresolved, as DP thymo-
cytes per se do not activate mature MAIT cells, it is likely that DP
cells present self-ligand/MR1 complexes to developing thymo-
cytes during intrathymic selection events. In line with this, mu-
tagenesis studies of both MR1 and iTCR indicate that binding
of exogenous versus endogenous ligands leads to different MR1/
ligand conformations (30).
Thymic and splenic B cells, DCs, and, to a greater extent, Macs
can stimulate MAIT cells in the presence of exogenous ligand,
supporting a role for these cell types in regulatingMAIT cell function
(10, 11). However, in contrast to DP thymocytes, thymic APCs, as
well as conventional thymic epithelium, could not select intra-
thymic MAIT cell progenitors in either our RTOC or BM chimera
systems, indicating a specialized role for DP in this process. In the
absence of detectable surface MR1, it is unclear whether this dis-
parity is due to a physiological lack of MR1 presentation by epi-
thelium and other HC types and/or additional coreceptor signaling
required for complete MAIT selection. However, although unde-
tectable at steady state, increased MR1 transcript and intracellular
protein expression by DP likely correlates with increased surface
MR1 expression levels (26). Conversely, DP may present a spe-
cialized set of endogenous ligand to developing T cells favoring
MAIT cell selection, compared with other cell types.
The finding that DP thymocytes play a unique and nonredun-
dant role in the selection of both MAIT and NKT subsets raises
questions about the mechanisms underlying their respective de-
velopmental programs. Given the sequential rearrangement of V-J
genes, the availability of NKT and MAIT TCR a-chain segments
likely occurs late in DP development, indicating a similar tem-
poral window of selection (12). However, although both subsets
share common features, such as the expression of the ZBTB16
transcription factor and a DN/CD8aa subset in humans, NKT
cells display a clear TH2 potentiality and CD4 bias, whereas MAIT
cells have a predominant TH1/17 phenotype, CD8 bias, and dif-
ferential homing pattern (2, 31).
The strict temporal regulation ofMR1 transcript and intracellular
protein, as well as surface CD1d expression on DP thymocytes,
indicates DP thymocytes are primed to mediate selection of both
NKT and MAIT cell progenitors. DP thymocytes express detect-
able CD1d surface protein, and NKT cell development is likely
mediated by presentation of agonist self-ligand (8). In contrast, DP
thymocytes lack detectable MR1 surface expression, and although
microbial-derived riboflavin metabolites are capable of activat-
ing mature MAIT cells, the identity of the endogenous ligand(s)
remains unknown. Thus, it is possible that early differences in avidity/
affinity of the NKT/MAIT TCR with their respective CD1d/MR1
ligand complex may govern the initiation of distinct developmen-
tal programs.
Cosignaling through SLAM/SAP/Fyn pathways is further re-
quired for complete NKT cell differentiation and may be tempo-
rally and physically linked to the CD1d-TCR triggering (32, 33). In
contrast, MAIT cell development appears to be SAP independent,
as MAIT cells are present at quasinormal levels in SAP-deficient
patients in whom NKT cells are virtually absent (7). Because DP
thymocytes express high levels of SLAM receptors (33), the
revelation of a common thymic selecting element indicates that
both NKT and MAIT progenitors likely encounter SLAM proteins
on their DP counterparts during development. One possibility is that
low-level surface MR1 on DP thymocytes, as well as the constant
shuttling of MR1 molecules between the intracellular and membrane
compartments, may lead to differential SLAM receptor recruitment
and/or SAP signal transduction in comparison with the NKT cell
development. This possibility would result in the regulation of a
specific developmental program during MAIT cell selection.
Acknowledgments
We thank the technical staff at the Curie Animal Facility (in particular
Colin Jouhanneau), the staff at the Evry Animal facility, as well as Zofia
Maciorowski, Annick Viguier, and Sophie Grondin from the Curie Cytometry
Platform for expert cell sorting, and A. Lehuen (INSERM) for the gift of
TCRa knockout bone marrow.
Disclosures
The authors have no financial conflicts of interest.
References
1. Rodgers, J. R., and R. G. Cook. 2005. MHC class Ib molecules bridge innate and
acquired immunity. Nat. Rev. Immunol. 5: 459–471.
2. Treiner, E., L. Duban, S. Bahram, M. Radosavljevic, V. Wanner, F. Tilloy,
P. Affaticati, S. Gilfillan, and O. Lantz. 2003. Selection of evolutionarily
conserved mucosal-associated invariant T cells by MR1. Nature 422: 164–
169.
FIGURE 4. DP thymocytes preferentially present bacterial ligand to
MAIT cells. (A) Activation of iVa19 Tg splenic cells with bacterial ligand
(1 U/ml) after overnight incubation with purified thymocyte subset from
MR12/2 or MR1+/+ mice. (B) Dose–response curves of Va19 Tg activa-
tion. (C) Incubation of DP thymocytes with bacterial ligand rapidly
increases MR1 expression. Fresh DPs were stained with anti-MR1 Ab at
0 or 4 h following incubation with bacterial ligand. FACS plots are rep-
resentative (n . 5) from two to three independent experiments. Activation
data are pooled from three independent experiments. *p , 0.05, DP ac-
tivation compared with all other samples.
6008 THYMIC SELECTION OF MAIT CELLS
 at IN
S
E
R
M
 D
IS
C
 D
O
C
 o
n
 F
eb
ru
ary
 1
8
, 2
0
1
4
h
ttp
://w
w
w
.jim
m
u
n
o
l.o
rg
/
D
o
w
n
lo
ad
ed
 fro
m
 
3. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells.
Annu. Rev. Immunol. 25: 297–336.
4. Tilloy, F., E. Treiner, S. H. Park, C. Garcia, F. Lemonnier, H. de la Salle,
A. Bendelac, M. Bonneville, and O. Lantz. 1999. An invariant T cell receptor
alpha chain defines a novel TAP-independent major histocompatibility complex
class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med.
189: 1907–1921.
5. Tsukamoto, K., J. E. Deakin, J. A. Graves, and K. Hashimoto. 2013. Excep-
tionally high conservation of the MHC class I-related gene, MR1, among
mammals. Immunogenetics 65: 115–124.
6. Dusseaux, M., E. Martin, N. Serriari, I. Pe´guillet, V. Premel, D. Louis,
M. Milder, L. Le Bourhis, C. Soudais, E. Treiner, and O. Lantz. 2011. Human
MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting
T cells. Blood 117: 1250–1259.
7. Martin, E., E. Treiner, L. Duban, L. Guerri, H. Laude, C. Toly, V. Premel,
A. Devys, I. C. Moura, F. Tilloy, et al. 2009. Stepwise development of
MAIT cells in mouse and human. PLoS Biol. 7: e54.
8. Rossjohn, J., D. G. Pellicci, O. Patel, L. Gapin, and D. I. Godfrey. 2012. Rec-
ognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol.
12: 845–857.
9. Kjer-Nielsen, L., O. Patel, A. J. Corbett, J. Le Nours, B. Meehan, L. Liu,
M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents
microbial vitamin B metabolites to MAIT cells. Nature 491: 717–723.
10. Le Bourhis, L., E. Martin, I. Pe´guillet, A. Guihot, N. Froux, M. Core´, E. Le´vy,
M. Dusseaux, V. Meyssonnier, V. Premel, et al. 2010. Antimicrobial activity of
mucosal-associated invariant T cells. Nat. Immunol. 11: 701–708.
11. Gold, M. C., S. Cerri, S. Smyk-Pearson, M. E. Cansler, T. M. Vogt, J. Delepine,
E. Winata, G. M. Swarbrick, W. J. Chua, Y. Y. Yu, et al. 2010. Human mucosal
associated invariant T cells detect bacterially infected cells. PLoS Biol. 8:
e1000407.
12. Le Bourhis, L., L. Guerri, M. Dusseaux, E. Martin, C. Soudais, and O. Lantz.
2011. Mucosal-associated invariant T cells: unconventional development and
function. Trends Immunol. 32: 212–218.
13. Bendelac, A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing
cortical thymocytes. J. Exp. Med. 182: 2091–2096.
14. Gold, M. C., T. Eid, S. Smyk-Pearson, Y. Eberling, G. M. Swarbrick,
S. M. Langley, P. R. Streeter, D. A. Lewinsohn, and D. M. Lewinsohn. 2013.
Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effec-
tors that adapt following thymic egress. Mucosal Immunol. 6: 35–44.
15. Walker, L. J., Y. H. Kang, M. O. Smith, H. Tharmalingham, N. Ramamurthy,
V. M. Fleming, N. Sahgal, A. Leslie, Y. Oo, A. Geremia, et al. 2012. Human
MAIT and CD8aa cells develop from a pool of type-17 precommitted CD8+
T cells. Blood 119: 422–433.
16. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li,
O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the
effector program of the NKT cell lineage. Immunity 29: 391–403.
17. Urdahl, K. B., J. C. Sun, and M. J. Bevan. 2002. Positive selection of MHC class
Ib-restricted CD8(+) T cells on hematopoietic cells. Nat. Immunol. 3: 772–779.
18. Bediako, Y., Y. Bian, H. Zhang, H. Cho, P. L. Stein, and C. R. Wang. 2012. SAP
is required for the development of innate phenotype in H2-M3—restricted Cd8
(+) T cells. J. Immunol. 189: 4787–4796.
19. Cho, H., Y. Bediako, H. Xu, H. J. Choi, and C. R. Wang. 2011. Positive selecting
cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells.
Proc. Natl. Acad. Sci. USA 108: 13241–13246.
20. Wei, D. G., H. Lee, S. H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and
A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell
lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp.
Med. 202: 239–248.
21. Gray, D. H., A. P. Chidgey, and R. L. Boyd. 2002. Analysis of thymic stromal
cell populations using flow cytometry. J. Immunol. Methods 260: 15–28.
22. Chua, W. J., S. Kim, N. Myers, S. Huang, L. Yu, D. H. Fremont, M. S. Diamond,
and T. H. Hansen. 2011. Endogenous MHC-related protein 1 is transiently
expressed on the plasma membrane in a conformation that activates mucosal-
associated invariant T cells. J. Immunol. 186: 4744–4750.
23. Shinkai, Y., and F. W. Alt. 1994. CD3 epsilon-mediated signals rescue the de-
velopment of CD4+CD8+ thymocytes in RAG-2-/- mice in the absence of TCR
beta chain expression. Int. Immunol. 6: 995–1001.
24. Seach, N., M. Hammett, and A. Chidgey. 2013. Isolation, characterization, and
reaggregate culture of thymic epithelial cells. Methods Mol. Biol. 945: 251–272.
25. Guerri, L., I. Peguillet, Y. Geraldo, S. Nabti, V. Premel, and O. Lantz. 2013.
Analysis of APC types involved in CD4 tolerance and regulatory T cell gener-
ation using reaggregated thymic organ cultures. J. Immunol. 190: 2102–2110.
26. Huang, S., S. Gilfillan, M. Cella, M. J. Miley, O. Lantz, L. Lybarger,
D. H. Fremont, and T. H. Hansen. 2005. Evidence for MR1 antigen presentation
to mucosal-associated invariant T cells. J. Biol. Chem. 280: 21183–21193.
27. Jenkinson, E. J., G. Anderson, and J. J. Owen. 1992. Studies on T cell maturation
on defined thymic stromal cell populations in vitro. J. Exp. Med. 176: 845–853.
28. Bendelac, A., P. Matzinger, R. A. Seder, W. E. Paul, and R. H. Schwartz. 1992.
Activation events during thymic selection. J. Exp. Med. 175: 731–742.
29. Erman, B., L. Feigenbaum, J. E. Coligan, and A. Singer. 2002. Early TCRalpha
expression generates TCRalphagamma complexes that signal the DN-to-DP
transition and impair development. Nat. Immunol. 3: 564–569.
30. Young, M. H., L. U’Ren, S. Huang, T. Mallevaey, J. Scott-Browne, F. Crawford,
O. Lantz, T. H. Hansen, J. Kappler, P. Marrack, and L. Gapin. 2013. MAIT cell rec-
ognition of MR1 on bacterially infected and uninfected cells. PLoS ONE 8: e53789.
31. Treiner, E., L. Duban, I. C. Moura, T. Hansen, S. Gilfillan, and O. Lantz. 2005.
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell
subset. Microbes Infect. 7: 552–559.
32. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons,
S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Reg-
ulation of NKT cell development by SAP, the protein defective in XLP. Nat.
Med. 11: 340–345.
33. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei,
A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions
mediated by Slamf1 and Slamf6 receptors control NKT cell lineage develop-
ment. Immunity 27: 751–762.
The Journal of Immunology 6009
 at IN
S
E
R
M
 D
IS
C
 D
O
C
 o
n
 F
eb
ru
ary
 1
8
, 2
0
1
4
h
ttp
://w
w
w
.jim
m
u
n
o
l.o
rg
/
D
o
w
n
lo
ad
ed
 fro
m
 
